No definition available.
Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)
C3_LUNG_NONSMALL_EXALLC
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
6680 |
4. Check minimum number of eventsNone |
6680 |
5. Include endpointsNone |
6680 |
6. Filter based on genotype QC (FinnGen only) |
6680 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE_EXALLC
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)
based on the number of shared cases.
Similar with more cases:
- Non-small cell lung cancer
- Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)
- Lung cancer and mesothelioma
- Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 6680 | 2060 | 4620 |
| Unadjusted period prevalence (%) | 1.63 | 0.70 | 2.04 |
| Median age at first event (years) | 71.02 | 68.99 | 71.92 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 6047
- Matched controls
- 56411
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
23.5
323.0
3350
2832
8000/3-C34.9
ICD-O-3
Neoplasm, malignant of lung, NOS
+∞
323.0
359
*
8140/3-C34.3
ICD-O-3
Adenocarcinoma, NOS, of lower lobe, lung
+∞
323.0
467
*
H02AB02
ATC
dexamethasone; systemic
116.9
323.0
1821
207
130
Kela drug reimbursment
Malignant tumour
+∞
323.0
2857
*
A04AA02
ATC
granisetron; systemic, transdermal
431.5
323.0
589
14
A04AA55
ATC
palonosetron, combinations; systemic
+∞
323.0
348
*
8070/3-C34.3
ICD-O-3
Squamous cell carcinoma, NOS, of lower lobe, lung
+∞
323.0
349
*
8140/3-C34.1
ICD-O-3
Adenocarcinoma, NOS, of upper lobe, lung
+∞
323.0
761
*
C34.3
ICD-10 Finland
Malignant neoplasm: Lower lobe, bronchus or lung
+∞
323.0
809
*
C34.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bronchus and lung
+∞
323.0
459
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
141.2
323.0
449
32
C34.9
ICD-10 Finland
Malignant neoplasm: Bronchus or lung, unspecified
4859.4
323.0
490
*
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
105.3
323.0
2078
279
JN4AD
NOMESCO Finland
Body CT examination
10.2
323.0
759
785
GD1AD
NOMESCO Finland
Thorax CT examination
9.6
323.0
777
850
A03FA01
ATC
metoclopramide; systemic, rectal
11.9
323.0
2386
2916
A04AA01
ATC
ondansetron; systemic, rectal
33.2
323.0
979
326
C34.90
ICD-10 Finland
Malignant tumor in unspecified location in bronchus and lung without histology
2525.2
323.0
517
*
N02AA05
ATC
oxycodone; systemic
6.5
323.0
1924
3752
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
185.3
323.0
941
56
JN4BD
NOMESCO Finland
Extensive body CT
10.6
323.0
1223
1317
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
1042.4
323.0
694
7
GDC01
NOMESCO Finland
Thoracoscopic lobectomy of lung
1691.4
323.0
910
6
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
355.6
323.0
684
20
UGC12
NOMESCO Finland
Flexible bronchoscopy
18.3
323.0
2565
2180
C34.92
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary adenocarcinoma
+∞
323.0
322
*
Z51.5
ICD-10 Finland
Palliative care
19.9
323.0
1051
590
C34.00
ICD-10 Finland
Malignant tumor of the main bronchus without histology
+∞
323.0
336
*
C34.82
ICD-10 Finland
Malignant overall tumor of bronchial and pulmonary adenocarcinoma
+∞
323.0
515
*
L01CA04
ATC
vinorelbine; systemic
+∞
323.0
566
*
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
16384.0
323.0
1528
*
WF002
NOMESCO Finland
Radical radiotherapy
237.2
323.0
718
32
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
4.1
323.0
1886
5604
XX3DW
NOMESCO Finland
Time consuming IT work
10.0
323.0
974
1064
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
323.0
423
*
C34.10
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung without histology
+∞
323.0
713
*
C34.32
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma
+∞
323.0
938
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
323.0
494
*
8070/3-C34.1
ICD-O-3
Squamous cell carcinoma, NOS, of upper lobe, lung
+∞
323.0
429
*
C34.11
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma
+∞
323.0
966
*
WZC30
NOMESCO Finland
Teaching
5.4
323.0
1182
2433
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
2268.9
323.0
470
*
C34.99
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology
+∞
323.0
422
*
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
9.8
323.0
1004
1125
WF004
NOMESCO Finland
Palliative radiotherapy
2943.5
323.0
592
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
361.3
323.0
502
14
WF049
NOMESCO Finland
Radiotherapy of metastasis
2977.2
323.0
859
*
GDC00
NOMESCO Finland
Lobectomy of lung
561.0
323.0
599
11
C34.19
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology
+∞
323.0
361
*
C34.30
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung without histology
+∞
323.0
436
*
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
26.5
323.0
760
304
C34.1
ICD-10 Finland
Malignant neoplasm: Upper lobe, bronchus or lung
+∞
323.0
1187
*
8070/3-C34.9
ICD-O-3
Squamous cell carcinoma, NOS, of lung, NOS
+∞
323.0
984
*
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
+∞
323.0
349
*
8140/3-C34.9
ICD-O-3
Adenocarcinoma, NOS, of lung, NOS
+∞
323.0
832
*
C34.31
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma
+∞
323.0
710
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
3.3
300.1
1957
7170
C34.81
ICD-10 Finland
Malignant overall tumor of bronchial and pulmonary epidermoid carcinoma
+∞
299.9
293
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
294.7
288
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
2731.7
293.3
289
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
410.6
288.6
295
7
GD5AD
NOMESCO Finland
Thorax and upper abdomen combined CT examination of
30.5
285.3
395
129
R84
ICPC
Malignant neoplasm bronchus/lung
460.8
278.9
284
6
116
Kela drug reimbursment
Prostate cancer
+∞
277.1
271
*
XGX32
NOMESCO Finland
Bronchoscopic ultrasonography
52.6
276.7
341
64
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
2477.5
267.5
264
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
12.0
263.6
510
429
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
9.0
259.1
588
669
C34.39
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung other or unspecified histology
+∞
255.5
250
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
470.0
238.6
243
5
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.5
236.4
3142
17169
L03AA13
ATC
pegfilgrastim; parenteral
741.6
228.7
230
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
286.7
226.0
235
8
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.5
224.0
2434
11820
C34.91
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary epidermoid carcinoma
+∞
220.5
216
*
C34.01
ICD-10 Finland
Malignant tumor of the main bronchial epidermoid carcinoma
+∞
219.5
215
*
TGD00
NOMESCO Finland
Needle biopsy of lung
79.1
210.6
244
30
ZX070
NOMESCO Finland
Intensity modified radiotherapy
1916.2
210.0
208
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
209.2
205
*
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
39.8
201.7
262
64
R03BB04
ATC
tiotropium bromide; inhalant
3.1
195.1
1294
4580
C34.80
ICD-10 Finland
Malignant overall tumor of bronchus and lung without histology
+∞
192.8
189
*
YG1CD
NOMESCO Finland
Very extensive CT examination of thorax for dose design of radiotherapy
+∞
191.7
188
*
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.7
187.9
939
2675
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
6.1
187.5
553
914
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
14.0
187.3
336
236
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
10.7
185.6
379
351
C34.22
ICD-10 Finland
Malignant tumor of the middle lobe, bronchus or lung adenocarcinoma
+∞
183.5
180
*
A04AD12
ATC
aprepitant; systemic
+∞
183.5
180
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
159.0
183.5
198
12
WF003
NOMESCO Finland
Adjuvant radiotherapy
256.2
177.7
186
7
115
Kela drug reimbursment
Breast cancer
+∞
175.3
172
*
191
Kela drug reimbursment
Erlotinib
+∞
171.2
168
*
C34.0
ICD-10 Finland
Malignant neoplasm: Main bronchus
+∞
171.2
168
*
UGC18
NOMESCO Finland
Flexible bronchoscopy with biopsy of lung
44.1
169.1
215
47
GDB21
NOMESCO Finland
Thoracoscopic segmental resection of lung
212.4
167.3
177
8
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
167.1
164
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
405.5
165.9
170
*
ZX120
NOMESCO Finland
Intravenous
3.9
165.7
752
1959
GD1AT
NOMESCO Finland
Biopsy of the lung with ultrasound guidance
154.5
163.6
177
11
PJA12
NOMESCO Finland
Sentinel node biopsy
398.0
162.8
167
*
H02AB06
ATC
prednisolone; systemic
2.1
161.5
3081
18637
L02AE02
ATC
leuprorelin; implant, parenteral
95.0
157.2
178
18
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
55.4
155.7
190
33
AA1BD
NOMESCO Finland
Extensive CT of head and brain
9.2
154.7
342
365
B01AB05
ATC
enoxaparin; parenteral
2.3
152.3
1930
9663
JN4CD
NOMESCO Finland
Very extensive body CT
9.9
152.3
323
320
C34.15
ICD-10 Finland
Malignant tumor of the anterior, bronchial or lung other non-microcellular carcinoma
+∞
149.7
147
*
J01MA12
ATC
levofloxacin; systemic
2.5
144.2
1436
6341
ZX050
NOMESCO Finland
Stereotactic radiotherapy
123.6
140.6
155
12
L01XE03
ATC
[U] erlotinib; oral
+∞
139.5
137
*
N02AX02
ATC
tramadol; systemic, rectal
2.0
138.8
2716
16228
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
666.6
138.7
140
*
C34.21
ICD-10 Finland
Malignant tumor of the middle lobe, bronchus or lung epidermoid carcinoma
+∞
138.5
136
*
155
Kela drug reimbursment
Afatinib and gefitinib
+∞
138.5
136
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
137.5
135
*
A98
ICPC
Health maint/preventive medicine
0.5
136.8
3536
41779
L03AA02
ATC
filgrastim; parenteral
75.7
135.7
158
20
C34.2
ICD-10 Finland
Malignant neoplasm: Middle lobe, bronchus or lung
+∞
134.4
132
*
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
3.8
134.1
626
1656
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
1274.0
133.3
133
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
1274.0
133.3
133
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
1262.8
132.3
132
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.3
131.9
1528
7233
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
5.7
129.6
402
700
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
129.3
127
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.4
128.7
1328
5925
N02AA01
ATC
morphine; systemic, rectal
13.2
128.4
235
172
C34.89
ICD-10 Finland
Malignant overall tumor of the bronchus and lung other or unspecified histology
+∞
128.3
126
*
A06AH03
ATC
naloxegol; oral
31.7
128.2
175
53
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
4.8
125.7
450
922
A79
ICPC
Malignancy NOS
130.7
125.0
137
10
B01AB10
ATC
tinzaparin; parenteral
4.5
123.5
471
1030
J01MA14
ATC
moxifloxacin; systemic
3.1
123.0
777
2585
R04.2
ICD-10 Finland
Haemoptysis
4.4
121.4
476
1069
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
297.1
121.4
126
*
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
564.2
117.3
119
*
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
5.1
115.9
391
749
C34.02
ICD-10 Finland
Malignant tumor of the main bronchial adenocarcinoma
+∞
115.0
113
*
C34
ICD-10 Finland
Malignant neoplasm of bronchus and lung
+∞
114.0
112
*
GD2CT
NOMESCO Finland
Cytology of the lungs with CT guidance
191.8
113.7
121
6
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
226.3
113.0
119
5
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
365.2
112.7
116
*
J93.8
ICD-10 Finland
Other pneumothorax
29.2
110.0
153
50
C34.35
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung other non-microcellular carcinoma
+∞
109.9
108
*
1623A
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Upper lobe, bronchus or lung[NEOPL MAL LOB SUPER PULMONIS,CA EPIDERMOIDES]
+∞
109.9
108
*
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
51.1
108.5
134
25
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.2
107.1
617
1913
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
106.8
105
*
C78.2
ICD-10 Finland
Secondary malignant neoplasm of pleura
+∞
106.8
105
*
R4110
NOMESCO Finland
Physiotherapy
2.1
104.9
1591
8345
D70.82
ICD-10 Finland
Drug-induced neutropenia
31.0
104.4
143
44
GDB11
NOMESCO Finland
Thoracoscopic wedge resection of lung
47.6
104.0
130
26
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
103.7
102
*
L02BB03
ATC
bicalutamide; oral
336.0
103.6
107
*
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
10.4
103.2
212
197
5826
FHL
Lobectomy or bilobectomy
119.3
102.3
113
9
GDD00
NOMESCO Finland
Pneumonectomy
254.6
102.2
107
*
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
6.3
101.5
286
439
WX402
NOMESCO Finland
General anaesthesia
2.7
100.8
801
3059
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
100.7
99
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
100.7
99
*
C34.20
ICD-10 Finland
Malignant tumor of the middle lobe, bronchus or lung without histology
+∞
100.7
99
*
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
37.0
100.4
132
34
L02BG04
ATC
letrozole; oral
69.6
99.5
117
16
R03AK03
ATC
[D] fenoterol & other drugs for obstructive airway dis; inhalant
2.7
96.0
750
2829
1BA04
NOMESCO Finland
NA
+∞
95.6
94
*
Z51.0
ICD-10 Finland
Radiotherapy session
898.7
94.7
95
*
C77.1
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes
+∞
92.5
91
*
TPH04
NOMESCO Finland
Cathetrisation of vein
2.1
92.1
1320
6707
NK6AN
NOMESCO Finland
Total body bone isotope imaging
38.3
89.8
117
29
8010/3-C34.9
ICD-O-3
Carcinoma, NOS, of lung, NOS
+∞
89.5
88
*
C34.17
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary carcinoid
+∞
87.4
86
*
WX250
NOMESCO Finland
Intercostal blockade
58.6
87.1
105
17
R03AL06
ATC
olodaterol and tiotropium bromide; inhalant
5.8
85.7
258
431
L01BC06
ATC
capecitabine; oral
+∞
85.4
84
*
XG410
NOMESCO Finland
Flow-volume spirometry
3.6
84.9
416
1133
GD2AT
NOMESCO Finland
Cytology of the lungs with ultrasound guidance
67.8
84.8
100
14
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
279.3
84.5
88
*
L01XE13
ATC
[U] afatinib; oral
+∞
84.4
83
*
C34.09
ICD-10 Finland
Malignant tumor of the main bronchus other or unspecified histology
+∞
84.4
83
*
TGA30
NOMESCO Finland
Thoracocentesis
11.2
83.8
165
141
C34.16
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary microcellular carcinoma
+∞
83.3
82
*
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
399.8
82.9
85
*
C34.37
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung carcinoid
+∞
82.3
81
*
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
269.3
81.5
85
*
WW500
NOMESCO Finland
Blood transfusion
5.3
80.8
261
474
HAB40
NOMESCO Finland
Wedge excision of mammary gland
22.8
80.7
120
50
N07BA03
ATC
varenicline; oral
4.4
80.6
314
696
C79.31
ICD-10 Finland
Secondary malignant tumor of the cerebellum
+∞
80.3
79
*
GDC10
NOMESCO Finland
Bilobectomy of lung
+∞
80.3
79
*
R03AC02
ATC
salbutamol; inhalant
1.7
80.0
2813
19174
TGE00
NOMESCO Finland
Needle biopsy of mediastinum
32.7
79.3
107
31
L01CB01
ATC
etoposide; systemic
+∞
79.3
78
*
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
7.5
79.2
196
250
TGD04
NOMESCO Finland
Needle biopsy of the lungs in bronchoscopy
19.3
79.1
124
61
GD5CD
NOMESCO Finland
Thorax and upper abdomen combined very extensive CT examination of
18.0
79.1
127
67
GEA00
NOMESCO Finland
Mediastinoscopy
36.5
79.1
104
27
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
72.7
78.8
92
12
J70.0
ICD-10 Finland
Acute pulmonary manifestations due to radiation
+∞
78.3
77
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
77.2
76
*
ZX095
NOMESCO Finland
Combined chemoradiotherapy
+∞
77.2
76
*
8041/3-C34.9
ICD-O-3
Small cell carcinoma, NOS, of lung, NOS
+∞
77.2
76
*
Y77
ICPC
Malignant neoplasm prostate
114.8
76.8
85
7
HA1AA
NOMESCO Finland
X-ray mammography
5.9
76.3
225
366
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
76.2
75
*
HAC20
NOMESCO Finland
Total mastectomy
130.7
75.9
83
6
M05BX04
ATC
denosumab; parenteral
4.1
75.7
319
761
J94.8
ICD-10 Finland
Other specified pleural conditions
6.2
75.7
216
337
KCD02
NOMESCO Finland
Transurethral resection of bladder
15.1
75.2
129
81
N03AX16
ATC
pregabalin; oral
1.9
74.8
1349
7401
L02BA01
ATC
tamoxifen; oral
88.3
73.8
84
9
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
351.7
72.8
75
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
38.6
72.4
94
23
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.2
71.7
843
3888
1CD01
NOMESCO Finland
NA
+∞
71.1
70
*
3004
Kela drug reimbursment
Osimertinib
+∞
71.1
70
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
70.1
69
*
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
47.8
69.1
86
17
D38.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Respiratory organ, unspecified
41.6
68.9
88
20
N06DX01
ATC
memantine; oral
0.2
67.2
70
3148
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
67.0
66
*
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.9
66.9
443
1495
WX892
NOMESCO Finland
Monitored bed care
2.5
66.9
573
2255
8140/3-C34.2
ICD-O-3
Adenocarcinoma, NOS, of middle lobe, lung
+∞
66.0
65
*
341
Kela drug reimbursment
Afatinib and gefitinib
+∞
66.0
65
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.9
65.2
426
1425
C34.85
ICD-10 Finland
Malignant overall tumor of bronchial and pulmonary other non-microcellular carcinoma
+∞
65.0
64
*
8000/3-C34.1
ICD-O-3
Neoplasm, malignant of upper lobe, lung
+∞
65.0
64
*
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
+∞
65.0
64
*
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
2.5
64.8
565
2241
1519
Kela drug reimbursment
NA
+∞
64.0
63
*
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
42.5
63.7
81
18
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
69.9
63.2
74
10
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
63.0
62
*
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
3.9
62.0
274
682
C34.29
ICD-10 Finland
Malignant tumor of the middle lobe, bronchus or lung other or unspecified histology
+∞
62.0
61
*
YN7BD
NOMESCO Finland
Extensive CT examination of spine for dose design of radiotherapy
+∞
62.0
61
*
C34.13
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary bronchoalveolar carcinoma
+∞
60.9
60
*
TGC00
NOMESCO Finland
Bronchial lavation
4.2
60.2
241
548
TPH07
NOMESCO Finland
Cathetrisation of artery
2.2
59.2
639
2816
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
3.5
59.0
301
843
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
+∞
58.9
58
*
C34.14
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary macrocellular anaplastic carcinoma
+∞
57.9
57
*
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
9.3
57.7
124
126
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
7.7
57.6
139
171
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.1
56.9
735
3507
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
56.9
56
*
PJD99
NOMESCO Finland
Excision of other lymph nodes
+∞
56.9
56
*
ZXC96
NOMESCO Finland
Robot assisted procedure
12.5
56.1
104
79
L01EB04
ATC
osimertinib; oral
+∞
55.9
55
*
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
55.9
55
*
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.9
55.6
979
5258
1625A
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Lower lobe, bronchus or lung[NEOPL MAL LOBI INFERIORIS PULMONIS,CA EPIDERMOIDES]
+∞
54.8
54
*
C67.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of bladder
+∞
54.8
54
*
A02BC02
ATC
pantoprazole; systemic
1.5
53.7
3455
26288
GAA96
NOMESCO Finland
Other open or percutaneous drainage of pleural cavity
16.6
53.5
88
50
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.9
53.1
875
4584
R03BB01
ATC
ipratropium bromide; inhalant
2.4
52.3
465
1858
WX600
NOMESCO Finland
Single shot through catheter
18.2
52.2
83
43
8551/3-C34.1
ICD-O-3
Acinar cell cystadenocarcinoma of upper lobe, lung
+∞
51.8
51
*
C34.33
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung bronchoalveolar carcinoma
+∞
51.8
51
*
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
53.1
50.9
62
11
JN6AD
NOMESCO Finland
CT of torso and neck
14.6
50.9
88
57
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
50.8
50
*
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
+∞
49.8
49
*
8070/3-C34.0
ICD-O-3
Squamous cell carcinoma, NOS, of main bronchus
+∞
49.8
49
*
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
0.2
49.0
58
2432
B01AB04
ATC
dalteparin; parenteral
2.8
48.9
339
1174
R06.0
ICD-10 Finland
Dyspnoea
1.6
48.9
1510
9582
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
240.1
48.7
51
*
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.5
48.3
2335
16508
XF400
NOMESCO Finland
ECG with 12 standard connections
1.7
48.2
1158
6843
G30.1
ICD-10 Finland
Alzheimer disease with late onset
0.3
48.0
80
2774
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.7
47.7
1227
7392
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
122.2
47.4
52
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
122.2
47.4
52
*
R85
ICPC
Malignant neopl respiratory other
99.7
47.4
53
5
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
0.6
46.9
1349
17528
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
46.7
46
*
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
+∞
46.7
46
*
J93.9
ICD-10 Finland
Pneumothorax, unspecified
10.5
46.2
93
84
B02AA02
ATC
tranexamic acid; systemic
2.1
45.9
594
2823
GAB10
NOMESCO Finland
Antero- or postero-lateral thoracotomy
11.6
45.5
87
71
C34.34
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or hunga macrocellular anaplastic carcinoma
+∞
44.7
44
*
C34.95
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary other non-microcellular carcinoma
+∞
44.7
44
*
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
2.2
44.1
501
2250
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
15.5
44.0
74
45
8240/3-C34.3
ICD-O-3
Neuroendocrine tumor, NOS, of lower lobe, lung
+∞
43.7
43
*
L01XE02
ATC
[U] gefitinib; oral
+∞
43.7
43
*
C78.1
ICD-10 Finland
Secondary malignant neoplasm of mediastinum
+∞
43.7
43
*
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
30.8
43.5
59
18
A06AD11
ATC
lactulose; oral
1.7
43.4
1029
6036
P20
ICPC
Memory disturbance
0.5
43.3
302
5713
GAA31
NOMESCO Finland
Thoracoscopy
16.7
42.2
69
39
GD004
NOMESCO Finland
Palliative radiotherapy of trachea, bronchi and lungs
401.7
42.1
43
*
1BC05
NOMESCO Finland
NA
+∞
41.6
41
*
ZX013
NOMESCO Finland
Radiotherapy with large shaped fields - SSD therapy
392.3
41.0
42
*
N06DA02
ATC
donepezil; oral
0.3
40.9
82
2591
GCA05
NOMESCO Finland
Bronchoscopic laser therapy of lesion of bronchus
+∞
40.6
40
*
1623C
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Upper lobe, bronchus or lung[NEOPL MAL LOB SUPER PULMONIS,ADENOCARCINOMA]
+∞
40.6
40
*
C34.97
ICD-10 Finland
Malignant tumor in unspecified location in bronchial and pulmonary carcinoid
+∞
40.6
40
*
1CD02
NOMESCO Finland
NA
+∞
40.6
40
*
SFA10
NOMESCO Finland
Fillning on one surface of tooth
0.7
40.1
1312
16751
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
19.5
40.1
62
30
5828
FHL
Pneumectomy
197.1
39.7
42
*
N05CF01
ATC
zopiclone; oral
1.5
39.7
1887
13132
C34.86
ICD-10 Finland
Malignant overall tumor of bronchial and pulmonary microcellular carcinoma
+∞
39.6
39
*
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
4.9
39.6
135
262
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
0.6
39.5
744
10687
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
38.6
38
*
8250/3-C34.9
ICD-O-3
Lepidic adenocarcinoma of lung, NOS
+∞
38.6
38
*
C79.7
ICD-10 Finland
Secondary malignant neoplasm of adrenal gland
+∞
38.6
38
*
A04AA03
ATC
tropisetron; systemic
+∞
38.6
38
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.9
38.2
243
797
SAA01
NOMESCO Finland
Simple examination of mouth
0.7
38.0
2017
23644
WW200
SPAT
NA
0.3
37.9
90
2624
KCD05
NOMESCO Finland
Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)
25.4
37.9
54
20
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
0.6
37.8
772
10903
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
80.8
37.6
43
5
M17.1
ICD-10 Finland
Other primary gonarthrosis
0.6
37.6
512
7979
GDC20
NOMESCO Finland
Lobectomy of lung and sleeve resection of bronchus
+∞
37.6
37
*
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
37.6
37
*
C50.91
ICD-10 Finland
Malignant tumor in another specified localization in ductal mammary gland
+∞
37.6
37
*
F17.29
ICD-10 Finland
Addiction caused by tobacco UNS
4.7
37.5
133
269
N06DA03
ATC
rivastigmine; oral, transdermal
0.2
37.3
32
1629
GD1BA
NOMESCO Finland
Extensive X-ray examination of thorax
4.6
37.2
135
280
D38.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Mediastinum
17.1
37.2
60
33
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
0.6
37.0
1027
13590
YX8VG
NOMESCO Finland
Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy
67.4
36.8
43
6
R03AL03
ATC
vilanterol and umeclidinium bromide; inhalant
4.8
36.7
128
255
J86.9
ICD-10 Finland
Pyothorax without fistula
5.7
36.6
109
181
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
+∞
36.5
36
*
8070/3-C34.2
ICD-O-3
Squamous cell carcinoma, NOS, of middle lobe, lung
+∞
36.5
36
*
3001
Kela drug reimbursment
Alectinib
+∞
36.5
36
*
SPAT1053
SPAT
Memory test
0.6
36.5
463
7355
F03
ICD-10 Finland
Unspecified dementia
0.3
36.4
65
2181
SAA02
NOMESCO Finland
Basic examination of mouth
0.7
36.3
1668
20102
C50
ICD-10 Finland
Malignant neoplasm of breast
344.8
36.0
37
*
7931A
ICD-9 Finland
Nonspecific abnormal findings on radiological and other examination of body structure, Lung field
7.7
35.9
86
106
WF099
NOMESCO Finland
Other radiotherapy
32.2
35.9
48
14
R50.9
ICD-10 Finland
Fever, unspecified
1.8
35.7
695
3819
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
+∞
35.5
35
*
1504
Kela drug reimbursment
Alectinib
+∞
35.5
35
*
8046/3-C34.9
ICD-O-3
Non-small cell carcinoma of lung, NOS
+∞
35.5
35
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
35.5
35
*
8240/3-C34.9
ICD-O-3
Neuroendocrine tumor, NOS, of lung, NOS
+∞
35.5
35
*
C79.39
ICD-10 Finland
Secondary malignant tumor of the meninges, ventricle or other part of the brain
+∞
34.5
34
*
C79.3
ICD-10 Finland
Secondary malignant neoplasm of brain and cerebral meninges
+∞
34.5
34
*
C34.36
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung microcellular carcinoma
+∞
34.5
34
*
8480/3-C34.3
ICD-O-3
Mucinous adenocarcinoma of lower lobe, lung
+∞
34.5
34
*
SPAT1109
SPAT
Analgesia with portable analgesic pump
11.8
34.5
65
52
Z72.0
ICD-10 Finland
Tobacco use
3.8
34.4
151
375
J01AA02
ATC
doxycycline; systemic
1.4
34.3
4184
34490
G30.9
ICD-10 Finland
Alzheimer disease, unspecified
0.2
34.1
38
1653
M05BA02
ATC
clodronic acid; systemic
89.2
33.7
38
*
R03AK07
ATC
formoterol and budesonide; inhalant
1.6
33.6
899
5419
J44
ICD-10 Finland
Other chronic obstructive pulmonary disease
3.0
33.6
203
643
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
2.4
33.5
312
1272
GDC11
NOMESCO Finland
Thoracoscopic bilobectomy of lung
+∞
33.5
33
*
YX9CD
NOMESCO Finland
Other very extensive CT eamination for dose design of radiotherapy
+∞
33.5
33
*
C18.71
ICD-10 Finland
Malignant tumor of the sigmoid invasive carcinoma
+∞
33.5
33
*
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
+∞
33.5
33
*
8000/3-C34.3
ICD-O-3
Neoplasm, malignant of lower lobe, lung
+∞
33.5
33
*
1240
FHL
Bronchoscopy
4.1
33.5
135
311
GDB10
NOMESCO Finland
Wedge resection of lung
36.7
33.1
43
11
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
316.3
33.0
34
*
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
316.3
33.0
34
*
D38.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Pleura
33.6
32.5
43
12
8551/3-C34.3
ICD-O-3
Acinar cell cystadenocarcinoma of lower lobe, lung
+∞
32.5
32
*
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
+∞
32.5
32
*
YN7AD
NOMESCO Finland
CT examination of spine for dose design of radiotherapy
+∞
32.5
32
*
1623X
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Upper lobe, bronchus or lung[NEOPL MAL LOB SUPER PULMONIS,EI HIST/SYTOL DG]
+∞
32.5
32
*
GD002
NOMESCO Finland
Radical radiotherapy of trachea, bronchi and lungs
+∞
32.5
32
*
GEA20
NOMESCO Finland
Mediastinoscopy with excision of lesion
23.2
32.3
47
19
GAC00
NOMESCO Finland
Biopsy of pleura
9.3
32.0
68
69
KEC00
NOMESCO Finland
Retropubic radical prostatectomy
159.4
31.8
34
*
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
+∞
31.5
31
*
8041/3-C34.1
ICD-O-3
Small cell carcinoma, NOS, of upper lobe, lung
+∞
31.5
31
*
THW99
NOMESCO Finland
Other minor procedure in surgery of mammary gland
21.6
31.0
46
20
GCA32
NOMESCO Finland
Endoscopic insertion of stent into bronch
67.6
30.9
36
5
R4190
NOMESCO Finland
Nutritional therapy
4.2
30.5
119
266
WF001
NOMESCO Finland
Preoperative radiotherapy
+∞
30.4
30
*
8310/3-C64.9
ICD-O-3
Clear cell adenocarcinoma, NOS, of kidney, NOS
+∞
30.4
30
*
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
+∞
30.4
30
*
8520/3-C50.9
ICD-O-3
Lobular carcinoma, NOS, of breast, NOS
+∞
30.4
30
*
8046/3-C34.1
ICD-O-3
Non-small cell carcinoma of upper lobe, lung
+∞
30.4
30
*
L01ED03
ATC
alectinib; oral
+∞
30.4
30
*
C34.96
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary microcellular carcinoma
+∞
30.4
30
*
C50.51
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor
+∞
30.4
30
*
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.6
30.0
863
5288
C34.27
ICD-10 Finland
Malignant tumor of the middle lobe, bronchus or lung carcinoid
+∞
29.4
29
*
L02BX02
ATC
degarelix; parenteral
+∞
29.4
29
*
C34.05
ICD-10 Finland
Malignant tumor of the main bronchial other non-microcellular carcinoma
+∞
29.4
29
*
169
Kela drug reimbursment
Crizotinib
+∞
29.4
29
*
GD2FN
NOMESCO Finland
Lung ventilation distribution isotope examination (radiospirometry)
+∞
29.4
29
*
8240/3-C34.1
ICD-O-3
Neuroendocrine tumor, NOS, of upper lobe, lung
+∞
29.4
29
*
C80.92
ICD-10 Finland
Malignant tumor without specified localization adenocarcinoma
+∞
29.4
29
*
L01XE35
ATC
[U] osimertinib; oral
+∞
29.4
29
*
J93.1
ICD-10 Finland
Other spontaneous pneumothorax
5.1
29.4
96
179
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
3.6
29.4
138
364
D38.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Larynx
14.8
28.9
49
31
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
6.2
28.6
79
120
8140/3-C18.7
ICD-O-3
Adenocarcinoma, NOS, of sigmoid colon
+∞
28.4
28
*
C38.1
ICD-10 Finland
Malignant neoplasm: Anterior mediastinum
+∞
28.4
28
*
L01EB03
ATC
afatinib; oral
+∞
28.4
28
*
D41.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bladder
6.4
28.2
76
112
XG460
NOMESCO Finland
Short time oxymetry
3.1
28.1
164
510
C18.70
ICD-10 Finland
Malignant tumor of the sigmoid without histology
273.4
28.0
29
*
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
273.4
28.0
29
*
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
2.8
27.7
185
628
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
5.0
27.4
91
173
WB111
NOMESCO Finland
Multiple neoadjuvant cytostatic therapy
+∞
27.4
27
*
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
+∞
27.4
27
*
8312/3-C64.9
ICD-O-3
Renal cell carcinoma, NOS, of kidney, NOS
+∞
27.4
27
*
128
Kela drug reimbursment
Cancers of female genital organs
+∞
27.4
27
*
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
12.4
27.3
50
38
2391A
ICD-9 Finland
Neoplasm of unspecified nature, Respiratory system
10.1
27.3
55
51
WX330
NOMESCO Finland
Paravertebral ansthesia
135.8
26.8
29
*
8130/2-C67.9
ICD-O-3
Papillary urothelial carcinoma, non-invasive of bladder, NOS
93.7
26.8
30
*
L15
ICPC
Knee symptom/complaint
0.6
26.5
443
6610
C32.0
ICD-10 Finland
Malignant neoplasm: Glottis
+∞
26.4
26
*
8070/3-C44.3
ICD-O-3
Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
26.4
26
*
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
26.4
26
*
C15.5
ICD-10 Finland
Malignant neoplasm: Lower third of oesophagus
+∞
26.4
26
*
8090/3-C44.4
ICD-O-3
Basal cell carcinoma, NOS, of skin of scalp and neck
+∞
26.4
26
*
ZX112
NOMESCO Finland
Subcutaneous
6.1
26.3
73
112
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
4.0
26.1
107
252
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
253.8
26.0
27
*
R52.0
ICD-10 Finland
Acute pain
3.1
25.7
146
444
G03HA01
ATC
cyproterone; systemic
17.9
25.4
40
21
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
+∞
25.4
25
*
M49.5*C79.5
ICD-10 Finland
Metastatic fracture of vertebra
+∞
25.4
25
*
L01XE36
ATC
[U] alectinib; oral
+∞
25.4
25
*
C34.84
ICD-10 Finland
Malignant overall tumor of bronchial and pulmonary macrocellular anaplastic carcinoma
+∞
25.4
25
*
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
34.4
25.2
33
9
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.4
25.2
1468
10439
EBA15
NOMESCO Finland
Extraction of large number of teeth
2.4
25.2
229
923
XX1AD
NOMESCO Finland
Other CT-examination
56.2
25.1
30
5
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
0.7
24.9
1006
12584
J43.9
ICD-10 Finland
Emphysema, unspecified
2.9
24.9
160
531
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
41.5
24.7
31
7
G04CA52
ATC
tamsulosin and dutasteride; systemic
0.6
24.5
311
4975
K02.1
ICD-10 Finland
Caries of dentine
0.7
24.5
1482
17392
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
24.3
24
*
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
+∞
24.3
24
*
C90.0
ICD-10 Finland
Multiple myeloma
+∞
24.3
24
*
C18.21
ICD-10 Finland
Malignant tumor of the ascending colon invasive carcinoma
+∞
24.3
24
*
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
+∞
24.3
24
*
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
24.3
24
*
325
Kela drug reimbursment
Erlotinib
+∞
24.3
24
*
GA3AT
NOMESCO Finland
Pleural cytology with ultrasound guidance
8.5
24.3
54
60
N04BA02
ATC
levodopa and decarboxylase inhibitor; oral
0.3
24.3
47
1514
KMAK
NOMESCO Finland
NA
0.7
24.2
1342
15966
UGC02
NOMESCO Finland
Rigid bronchoscopy
16.6
24.2
39
22
R03AL08
ATC
vilanterol, umeclidinium bromide and fluticasone furoate; inhalant
3.5
24.2
115
308
C44.39
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology
84.3
23.9
27
*
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
0.7
23.9
786
10207
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
0.6
23.8
607
8276
G20
ICD-10 Finland
Parkinson disease
0.3
23.4
39
1354
8090/3-C44.2
ICD-O-3
Basal cell carcinoma, NOS, of external ear
+∞
23.3
23
*
1628A
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Other parts of bronchus or lung[NEOPL MAL PULMONIS LOCO MULTIPLICI,CA EPIDERMOIDES]
+∞
23.3
23
*
1622A
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Main bronchus[NEOPL MAL BRONCH PRINCIP,CA EPIDERMOIDES]
+∞
23.3
23
*
8250/3-C34.3
ICD-O-3
Lepidic adenocarcinoma of lower lobe, lung
+∞
23.3
23
*
C71.90
ICD-10 Finland
Malignant tumor in unspecified localization in the brain without histology
+∞
23.3
23
*
C39.9
ICD-10 Finland
Malignant neoplasm: Ill-defined sites within the respiratory system
224.6
23.0
24
*
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
224.6
23.0
24
*
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
9.4
23.0
48
48
R03DA04
ATC
theophylline; systemic, rectal
1.7
23.0
480
2679
GA2AT
NOMESCO Finland
Pleural biopsy with ultrasound guidance
81.2
22.9
26
*
C10AA07
ATC
rosuvastatin; oral
0.7
22.7
723
9462
F00.10*G30.1
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
0.2
22.7
34
1252
EB1AA
NOMESCO Finland
Tooth X-ray examination
0.7
22.6
1539
17809
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
0.6
22.5
450
6462
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
9.0
22.5
48
50
8380/3-C54.1
ICD-O-3
Endometrioid adenocarcinoma, NOS, of endometrium
+∞
22.3
22
*
L01XE16
ATC
[U] crizotinib; oral
+∞
22.3
22
*
8250/3-C34.1
ICD-O-3
Lepidic adenocarcinoma of upper lobe, lung
+∞
22.3
22
*
C50.31
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor
+∞
22.3
22
*
GWE00
NOMESCO Finland
Reoperation for deep haemorrhage in thoracic surgery
26.4
22.3
31
11
R95
ICPC
Chron obstructive pulmonary disease
2.3
22.3
213
881
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
8.5
22.2
49
54
A07AA02
ATC
nystatin; oral
1.9
22.1
317
1560
110
Kela drug reimbursment
Parkinson's disease and comparable movement disrorders
0.2
22.1
33
1213
I10
ICD-10 Finland
Essential (primary) hypertension
0.8
22.1
2732
29219
8500/2-C50.9
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS
215.2
22.0
23
*
C50.11
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,ductal tumor
78.1
22.0
25
*
WF029
NOMESCO Finland
Radiotherapy of local residive tumor
112.3
21.9
24
*
D82
ICPC
Teeth/gum disease
0.7
21.8
693
9081
GDA10
NOMESCO Finland
Biopsy of lung
10.9
21.8
42
36
C10AA05
ATC
atorvastatin; oral
0.7
21.8
1576
18105
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
4.5
21.8
78
162
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
10.3
21.7
43
39
GDA98
NOMESCO Finland
Other bronchoscopic incision, excision of lesion or repair of lung
6.5
21.5
57
83
PJA10
NOMESCO Finland
Exploration of lymph nodes
8.3
21.5
48
54
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
0.6
21.5
318
4902
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.0
21.4
274
1290
C34.25
ICD-10 Finland
Malignant tumor of the middle lobe, bronchus or lung other non-microcellular carcinoma
+∞
21.3
21
*
GDA21
NOMESCO Finland
Thoracoscopic excision of lesion of lung
18.2
21.2
33
17
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.7
21.2
450
2524
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
2.8
21.2
137
456
N05AX08
ATC
risperidone; systemic
0.5
21.2
167
3061
L02BG03
ATC
anastrozole; oral
58.5
21.2
25
*
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
58.5
21.2
25
*
NGB20
NOMESCO Finland
Primary total prosthetic replacement of knee joint without patellar part
0.5
21.2
224
3768
D19
ICPC
Teeth/gum symptom/complaint
0.6
21.1
475
6659
GDB20
NOMESCO Finland
Segmental resection of lung
205.8
21.0
22
*
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
36.1
21.0
27
7
SDA01
NOMESCO Finland
Simple parodonthologic therapy
0.6
21.0
456
6440
SAD01
NOMESCO Finland
Assessment of need for oral health care, standard
0.5
20.9
141
2717
H13
ICPC
Plugged feeling ear
0.6
20.9
496
6876
J01FA06
ATC
roxithromycin; oral
1.3
20.7
1953
14930
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
5.0
20.7
68
129
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
7.5
20.7
49
61
RS221
NOMESCO Finland
NA
3.8
20.6
89
221
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
0.7
20.6
1273
14983
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
24.7
20.5
29
11
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
3.3
20.5
107
309
JDB10
NOMESCO Finland
Percutaneous gastrostomy
4.3
20.4
77
169
SPAT1310
SPAT
Counselling related to known health issue
0.7
20.3
917
11330
8140/3-C34.0
ICD-O-3
Adenocarcinoma, NOS, of main bronchus
+∞
20.3
20
*
C34.06
ICD-10 Finland
Malignant tumor of the main bronchial microcellular carcinoma
+∞
20.3
20
*
8070/3-C32.9
ICD-O-3
Squamous cell carcinoma, NOS, of larynx, NOS
+∞
20.3
20
*
8010/3-C34.1
ICD-O-3
Carcinoma, NOS, of upper lobe, lung
+∞
20.3
20
*
C34.83
ICD-10 Finland
Malignant overall tumor of bronchial and pulmonary bronchoalveolar carcinoma
+∞
20.3
20
*
C34.04
ICD-10 Finland
Malignant tumor of the main bronchial macrocellular anaplastic carcinoma
+∞
20.3
20
*
C38.4
ICD-10 Finland
Malignant neoplasm: Pleura
+∞
20.3
20
*
Z01.2
ICD-10 Finland
Dental examination
0.7
20.3
944
11603
HAE10
NOMESCO Finland
Reconstruction of breast using graft or flap
56.1
20.2
24
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
1.8
20.2
350
1841
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
3.3
20.2
104
298
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
0.7
20.1
891
11040
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
22.6
20.0
29
12
XF600
NOMESCO Finland
Bloodpressure measurement
1.8
20.0
332
1721
C18.00
ICD-10 Finland
Malignant tumor of the caecum without histology
196.4
20.0
21
*
ZX109
NOMESCO Finland
Instruction on medicine inhalation technique
4.6
19.9
70
143
Z25.8
ICD-10 Finland
Need for immunization against other specified single viral diseases
0.5
19.8
158
2886
Z03.1
ICD-10 Finland
Observation for suspected malignant neoplasm
3.4
19.7
96
264
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
0.6
19.7
384
5553
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
1.5
19.3
744
4846
C34.87
ICD-10 Finland
Malignant overall tumor of bronchial and pulmonary carcinoid
+∞
19.3
19
*
8140/3-C80.9
ICD-O-3
Adenocarcinoma, NOS, of unknown primary site
+∞
19.3
19
*
C18.01
ICD-10 Finland
Malignant tumor of the caecum invasive carcinoma
+∞
19.3
19
*
1744A
ICD-9 Finland
Malignant neoplasm of female breast, Upper-outer quadrant
+∞
19.3
19
*
JCF12
NOMESCO Finland
Endoscopic insertion of prosthetic tube into oesphagus
17.6
19.1
30
16
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
12.7
19.1
34
25
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
11.2
19.1
36
30
GDC13
NOMESCO Finland
Extended lobectomy or bilobectomy of lung
187.0
19.0
20
*
WE198
NOMESCO Finland
Palliative cystotatic therapy
187.0
19.0
20
*
I25.1
ICD-10 Finland
Atherosclerotic heart disease
0.7
18.8
1182
13919
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
1.9
18.8
276
1373
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.6
18.8
555
3406
UGB02
NOMESCO Finland
Tracheoscopy
20.2
18.7
28
13
L01EB01
ATC
gefitinib; oral (epidermal growth factor receptor (egfr) tyrosine kinase inhibitors)
+∞
18.3
18
*
C34.93
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary bronchoalveolar carcinoma
+∞
18.3
18
*
JN4DD
NOMESCO Finland
Scout CT scan of torso
32.1
18.2
24
7
A02BC01
ATC
omeprazole; systemic
1.3
18.1
1474
10981
A02BA02
ATC
ranitidine; systemic
1.4
18.0
1113
7931
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
177.7
18.0
19
*
B01AF01
ATC
rivaroxaban; oral
0.6
18.0
293
4420
SDA02
NOMESCO Finland
Parodonthologic therapy
0.7
17.9
745
9350
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
0.5
17.9
203
3349
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
0.7
17.8
594
7735
XX9XW
NOMESCO Finland
NA
6.5
17.7
46
66
ZZR00
NOMESCO Finland
Flap of skin
4.8
17.5
59
116
SPAT1043
SPAT
Audiometry
0.6
17.5
247
3858
7866A
ICD-9 Finland
Symptoms involving respiratory system and other chest symptoms, Swelling, mass, or lump in chest
20.3
17.5
26
12
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
1.7
17.4
345
1895
UJC01
NOMESCO Finland
Scopy of lower throat
4.8
17.4
58
113
X76
ICPC
Malignant neoplasm breast female
49.1
17.4
21
*
H02AB07
ATC
prednisone; oral
1.5
17.4
718
4745
VALMI
NOMESCO Finland
NA
0.7
17.3
450
6144
ZYC01
SPAT
NA
0.3
17.3
37
1133
WD205
NOMESCO Finland
Therapy of methastized malignancy with hormones
+∞
17.2
17
*
WF090
NOMESCO Finland
Profylactic radiotherapy
+∞
17.2
17
*
C77.8
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions
+∞
17.2
17
*
8140/3-C18.2
ICD-O-3
Adenocarcinoma, NOS, of ascending colon
+∞
17.2
17
*
C45.0
ICD-10 Finland
Mesothelioma of pleura
+∞
17.2
17
*
8090/3-C44.1
ICD-O-3
Basal cell carcinoma, NOS, of eyelid
+∞
17.2
17
*
8046/3-C34.3
ICD-O-3
Non-small cell carcinoma of lower lobe, lung
+∞
17.2
17
*
C18.20
ICD-10 Finland
Malignant tumor of the ascending colon without histology
+∞
17.2
17
*
C34.23
ICD-10 Finland
Malignant tumor of the middle lobe, bronchus or lung bronchoalveolar carcinoma
+∞
17.2
17
*
G47.3
ICD-10 Finland
Sleep apnoea
0.7
17.2
528
6984
ZXK00
NOMESCO Finland
Conversion from percutaneous endoscopic to open procedure
6.3
17.2
46
69
C25.9
ICD-10 Finland
Malignant neoplasm: Pancreas, unspecified
62.3
17.2
20
*
GD6BD
NOMESCO Finland
Extensive CT of chest and neck
15.4
17.1
28
17
GD6AD
NOMESCO Finland
CT of chest and neck
21.3
17.1
25
11
C32.1
ICD-10 Finland
Malignant neoplasm: Supraglottis
168.3
17.0
18
*
WC305
NOMESCO Finland
Simple therapy of local tumor recidive with biomodifiers
168.3
17.0
18
*
PJD81
NOMESCO Finland
Excision of lymph nodes from upper part of neck
168.3
17.0
18
*
ZXA00
NOMESCO Finland
Right side
1.3
16.8
1397
10415
XX1XW
NOMESCO Finland
Extensive written report from radiologist
2.8
16.8
108
362
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
4.8
16.6
55
107
G30.8
ICD-10 Finland
Other Alzheimer disease
0.2
16.5
20
825
SPAT1301
SPAT
No procedures
0.7
16.5
1047
12351
L02AE03
ATC
goserelin; implant
9.4
16.5
34
34
SPAT1325
SPAT
Vaccination
0.8
16.4
1268
14569
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
0.7
16.3
580
7480
N05BA04
ATC
oxazepam; oral
1.3
16.3
1147
8333
C09CA01
ATC
losartan; oral
0.7
16.3
784
9628
J61
ICD-10 Finland
Pneumoconiosis due to asbestos and other mineral fibres
3.2
16.3
86
253
Z02.4
ICD-10 Finland
Examination for driving licence
0.7
16.2
913
10959
SPAT1249
SPAT
Treatment-related counselling outside office
0.8
16.2
1256
14431
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
2.3
16.2
148
601
C50.4
ICD-10 Finland
Malignant neoplasm: Upper-outer quadrant of breast
+∞
16.2
16
*
C50.9
ICD-10 Finland
Malignant neoplasm: Breast, unspecified
+∞
16.2
16
*
C43.50
ICD-10 Finland
Malignant melanoma of the torso without histology
+∞
16.2
16
*
C20.92
ICD-10 Finland
Malignant tumor of the rectum carcinoma of the adenoma
+∞
16.2
16
*
C50.81
ICD-10 Finland
Overall malignant tumor of the mammary gland, ductal tumor
+∞
16.2
16
*
C22.0
ICD-10 Finland
Malignant neoplasm: Liver cell carcinoma
+∞
16.2
16
*
C34.07
ICD-10 Finland
Malignant tumor of the main bronchus carcinoid
+∞
16.2
16
*
YN1BD
NOMESCO Finland
Extensive CT examination of extremities for dose design of radiotherapy
+∞
16.2
16
*
WB401
NOMESCO Finland
Simple antibody therapy of primary tumour
+∞
16.2
16
*
C32.9
ICD-10 Finland
Malignant neoplasm: Larynx, unspecified
+∞
16.2
16
*
C67.4
ICD-10 Finland
Malignant neoplasm: Posterior wall of bladder
+∞
16.2
16
*
GCA02
NOMESCO Finland
Bronchoscopic electrocoagulation of lesion of bronchus
59.2
16.2
19
*
K03.64
ICD-10 Finland
Dental calculus supragingival
0.7
16.1
483
6427
P70
ICPC
Dementia
0.2
16.1
18
781
L02AE04
ATC
triptorelin; parenteral
84.2
16.1
18
*
C02.11
ICD-10 Finland
Malignant neoplasm of border of tongue
158.9
16.0
17
*
NJ2MA
NOMESCO Finland
Measurement of mechanical axis of lower leg with X-ray
0.5
16.0
110
2108
K03.82
ICD-10 Finland
Split tooth for reasons other than trauma
0.4
15.9
79
1694
TKE00
NOMESCO Finland
Needle biopsy of prostate
2.1
15.9
186
846
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.1
15.8
181
818
L13
ICPC
Hip symptom/complaint
0.7
15.8
383
5303
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
3.0
15.8
90
278
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.4
15.7
867
6045
5188X
ICD-9 Finland
Other diseases of lung
5.7
15.7
45
74
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
6.9
15.7
39
53
GDA11
NOMESCO Finland
Thoracoscopic biopsy of lung
6.6
15.6
40
57
B03BA03
ATC
hydroxocobalamin; parenteral
1.7
15.6
366
2113
JN3KE
NOMESCO Finland
Abdominal ultrasound with added contrast
8.0
15.5
35
41
E34.0
ICD-10 Finland
Carcinoid syndrome
44.4
15.5
19
*
HAE20
NOMESCO Finland
Reconstruction of areola and mamilla using graft or flap
44.4
15.5
19
*
C44.11
ICD-10 Finland
Basocellular carcinoma of the skin of the eyelids including the corner of the eye
44.4
15.5
19
*
S77
ICPC
Malignant neoplasm of skin
15.6
15.4
25
15
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
3.3
15.4
78
223
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
2.6
15.3
111
399
L17
ICPC
Foot/toe symptom/complaint
0.7
15.3
700
8675
HA4AT
NOMESCO Finland
Labeling mammary gland pathology with ultrasound guidance
8.6
15.3
33
36
C64
ICD-10 Finland
Malignant neoplasm of kidney, except renal pelvis
56.1
15.3
18
*
C34.94
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary macrocellular anaplastic carcinoma
+∞
15.2
15
*
C79.2
ICD-10 Finland
Secondary malignant neoplasm of skin
+∞
15.2
15
*
YA1CD
NOMESCO Finland
Very extensive CT examination of head and neck for dose design of radiotherapy
+∞
15.2
15
*
8720/3-C44.5
ICD-O-3
Malignant melanoma, NOS, of skin of trunk
+∞
15.2
15
*
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
+∞
15.2
15
*
C20.99
ICD-10 Finland
Malignant tumor of the rectum other or unspecified histology
+∞
15.2
15
*
C76.1
ICD-10 Finland
Malignant neoplasm of other and ill-defined sites: Thorax
+∞
15.2
15
*
8010/3-C34.3
ICD-O-3
Carcinoma, NOS, of lower lobe, lung
+∞
15.2
15
*
8140/2-C34.1
ICD-O-3
Adenocarcinoma in situ, NOS, of upper lobe, lung
+∞
15.2
15
*
C20
ICD-10 Finland
Malignant neoplasm of rectum
+∞
15.2
15
*
C34.03
ICD-10 Finland
Malignant tumor of the main bronchial bronchoalveolar carcinoma
+∞
15.2
15
*
SPAT1312
SPAT
General health counselling
0.7
15.2
873
10458
SCA01
NOMESCO Finland
Simple analysis and advice of nutrition with regard to dentistry
0.7
15.2
508
6629
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
2.0
15.1
200
957
N02AA03
ATC
hydromorphone; systemic, rectal
13.5
15.1
26
18
OAB42
SPAT
NA
0.3
15.1
38
1077
M75.1
ICD-10 Finland
Rotator cuff syndrome
0.7
15.0
650
8128
KAC10
NOMESCO Finland
Total nephrectomy with capsule
16.0
15.0
24
14
C10AX09
ATC
ezetimibe; oral
0.6
14.8
268
3951
H02
ICPC
Hearing complaint
0.6
14.8
325
4594
DAX08
NOMESCO Finland
Fitting of hearing aid
0.4
14.7
69
1508
ZX100
NOMESCO Finland
Oral
3.3
14.7
73
206
N04BD01
ATC
selegiline; oral
0.1
14.7
7
525
M01AX05
ATC
glucosamine; oral
0.7
14.6
643
8020
N05AD01
ATC
haloperidol; systemic
2.0
14.5
199
964
TPJ00
NOMESCO Finland
Biopsy of superficial lymph node
16.6
14.5
23
13
F01.9
ICD-10 Finland
Vascular dementia, unspecified
0.2
14.5
14
657
N06DA04
ATC
galantamine; oral
0.3
14.4
22
795
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
4.8
14.3
47
91
C44.71
ICD-10 Finland
Basocellular carcinoma of the skin of the lower extremity including the hip
53.0
14.3
17
*
WD315
NOMESCO Finland
Multiple therapy of methastized malignancy with biomodifiers
53.0
14.3
17
*
JN5AP
NOMESCO Finland
Total body PET (1 picture)
53.0
14.3
17
*
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
0.6
14.3
170
2774
8170/3-C22.0
ICD-O-3
Hepatocellular carcinoma, NOS, of liver
+∞
14.2
14
*
8480/3-C34.9
ICD-O-3
Mucinous adenocarcinoma of lung, NOS
+∞
14.2
14
*
1629X
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Bronchus and lung, unspecified[NEOPL MAL PULMONIS LOCO ALIO/NUD,EI HIST/SYTOL DG]
+∞
14.2
14
*
8240/3-C34.2
ICD-O-3
Neuroendocrine tumor, NOS, of middle lobe, lung
+∞
14.2
14
*
WB323
NOMESCO Finland
Demanding adjuvant therapy of malignancy with biomodifiers
+∞
14.2
14
*
TXQ05
NOMESCO Finland
Puncture of skin, site unspecified
+∞
14.2
14
*
L02BG06
ATC
exemestane; oral
+∞
14.2
14
*
C82.1
ICD-10 Finland
Follicular lymphoma grade II
+∞
14.2
14
*
C80
ICD-10 Finland
Malignant neoplasm, without specification of site
+∞
14.2
14
*
C80.99
ICD-10 Finland
Malignant tumor without specified localization or histology
+∞
14.2
14
*
163
Kela drug reimbursment
Abiraterone and enzalutamide
+∞
14.2
14
*
KE002
NOMESCO Finland
Radical radiotherapy of prostata and seminal vesicles
+∞
14.2
14
*
1629A
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Bronchus and lung, unspecified[NEOPL MAL PULMONIS LOCO ALIO/NUD,CA EPIDERMOIDES]
+∞
14.2
14
*
C77.9
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph node, unspecified
+∞
14.2
14
*
GA2CT
NOMESCO Finland
Pleural biopsy with CT guidance
+∞
14.2
14
*
363
Kela drug reimbursment
Crizotinib
+∞
14.2
14
*
H01CB03
ATC
lanreotide; parenteral
74.9
14.1
16
*
215
Kela drug reimbursment
Diabetes, non-insulin-treated
0.7
14.1
801
9627
GEB40
NOMESCO Finland
Mediastinotomy and extended excision of lesion
140.2
14.1
15
*
C43.31
ICD-10 Finland
Malignant melanoma of another or unspecified part of the face originating in lentigo maligna
140.2
14.1
15
*
OAB38
NOMESCO Finland
Psychosocial guidance and counselling
140.2
14.1
15
*
KCC10
NOMESCO Finland
Cystoprostatectomy
140.2
14.1
15
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
2.5
14.0
110
415
J92.0
ICD-10 Finland
Pleural plaque with presence of asbestos
2.1
14.0
167
769
L03
ICPC
Low back symptom/complaint
0.7
13.9
562
7112
QX4AT
NOMESCO Finland
Ultrsound guided needle biopsy of skin
8.1
13.9
31
36
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.3
13.8
952
6874
WZA10
NOMESCO Finland
Long statement of health and health related matters
3.7
13.8
60
152
J01DA01
ATC
[U] cefalexin; systemic
1.2
13.7
3120
26163
R05CB01
ATC
acetylcysteine; inhalant, oral
2.3
13.7
129
534
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
7.5
13.7
32
40
205
Kela drug reimbursment
Chronic hypertension
0.8
13.7
1373
15346
M17
ICD-10 Finland
Gonarthrosis [arthrosis of knee]
0.6
13.6
210
3212
L90
ICPC
Osteoarthrosis of knee
0.5
13.5
98
1843
R24
ICPC
Haemoptysis
4.2
13.4
51
115
KBJ10
NOMESCO Finland
Cutaneous ureteroenterostomy
49.8
13.4
16
*
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
0.8
13.3
1081
12400
JD1EE
NOMESCO Finland
Ultrasound examination of gastro-oesophageal reflux
22.2
13.3
19
8
I71.4
ICD-10 Finland
Abdominal aortic aneurysm, without mention of rupture
1.8
13.2
227
1194
8249/3-C34.3
ICD-O-3
Neuroendocrine tumor, grade 2 of lower lobe, lung
+∞
13.2
13
*
8041/3-C34.3
ICD-O-3
Small cell carcinoma, NOS, of lower lobe, lung
+∞
13.2
13
*
8380/3-C54.9
ICD-O-3
Endometrioid adenocarcinoma, NOS, of corpus uteri
+∞
13.2
13
*
8480/3-C34.1
ICD-O-3
Mucinous adenocarcinoma of upper lobe, lung
+∞
13.2
13
*
8013/3-C34.9
ICD-O-3
Large cell neuroendocrine carcinoma of lung, NOS
+∞
13.2
13
*
NA049
NOMESCO Finland
Radiotherapy of methastasis in spine
+∞
13.2
13
*
C38.3
ICD-10 Finland
Malignant neoplasm: Mediastinum, part unspecified
+∞
13.2
13
*
L01AX03
ATC
temozolomide; systemic
+∞
13.2
13
*
C67.0
ICD-10 Finland
Malignant neoplasm: Trigone of bladder
+∞
13.2
13
*
C17.9
ICD-10 Finland
Malignant neoplasm: Small intestine, unspecified
+∞
13.2
13
*
C81.9
ICD-10 Finland
Hodgkin lymphoma, unspecified
+∞
13.2
13
*
8720/3-C44.9
ICD-O-3
Malignant melanoma, NOS, of skin, NOS
+∞
13.2
13
*
C50.00
ICD-10 Finland
Malignant tumor of nipple and areola, no histological veryfication
+∞
13.2
13
*
HAB50
NOMESCO Finland
Partial excision of mammary gland with reconstructive operation
70.2
13.2
15
*
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.3
13.2
1167
8744
DAX00
NOMESCO Finland
Adjustment or review of hearing aid
0.4
13.1
74
1515
J98.1
ICD-10 Finland
Pulmonary collapse
4.0
13.1
52
122
TQW99
NOMESCO Finland
Other minor procedure on skin
2.0
13.1
165
775
DHB00
NOMESCO Finland
Excision of lesion of external nose
7.0
13.1
32
43
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
0.6
13.0
219
3280
JFB30
NOMESCO Finland
Right hemicolectomy
4.5
13.0
45
93
GDA20
NOMESCO Finland
Excision of lesion of lung
15.1
12.9
21
13
SPAT1097
SPAT
Recording of ECG
0.7
12.8
439
5708
A10BK03
ATC
empagliflozin; oral
0.5
12.7
117
2047
I50.0
ICD-10 Finland
Congestive heart failure
0.6
12.7
286
4027
KFC10
NOMESCO Finland
Bilateral orchiectomy
37.3
12.7
16
*
L08
ICPC
Shoulder symptom/complaint
0.7
12.7
478
6123
Z73.3
ICD-10 Finland
Stress, not elsewhere classified
4.3
12.6
46
100
N03AX14
ATC
levetiracetam; systemic
2.3
12.6
119
496
M01AH05
ATC
etoricoxib; oral
0.8
12.5
1865
20015
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
0.8
12.5
1037
11873
K05.31
ICD-10 Finland
Periodontitis pronounced
1.5
12.5
447
2861
C44.21
ICD-10 Finland
Basocellular carcinoma of the skin of the outer ear and the outer ear canal
46.7
12.4
15
*
HAB99
NOMESCO Finland
Other partial excision of mammary gland
5.2
12.4
38
69
SPAT1256
SPAT
Intramuscular and subcutaneous injection
0.8
12.4
1460
16064
FN2BA
NOMESCO Finland
Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)
0.5
12.2
126
2135
9707
FHL
Ablation of mammae and removal of axillary lymph nodes
65.5
12.2
14
*
M84.4
ICD-10 Finland
Pathological fracture, not elsewhere classified
10.8
12.2
23
20
8012/3-C34.1
ICD-O-3
Large cell carcinoma, NOS, of upper lobe, lung
+∞
12.2
12
*
C18.30
ICD-10 Finland
Malignant tumor of flexura hepatica without histology
+∞
12.2
12
*
GD003
NOMESCO Finland
Adjuvant radiotherapy of trachea, bronchi and lungs
+∞
12.2
12
*
C50.20
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,no histological veryfication
+∞
12.2
12
*
8550/3-C34.1
ICD-O-3
Acinar cell carcinoma of upper lobe, lung
+∞
12.2
12
*
C43.32
ICD-10 Finland
Malignant melanoma of another or unspecified part of the face 'superficial spreading' type
+∞
12.2
12
*
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
+∞
12.2
12
*
8140/3-C34.8
ICD-O-3
Adenocarcinoma, NOS, of overlapping lesion of lung
+∞
12.2
12
*
8097/3-C44.9
ICD-O-3
Basal cell carcinoma, nodular of skin, NOS
+∞
12.2
12
*
1625C
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Lower lobe, bronchus or lung[NEOPL MAL LOBI INFERIORIS PULMONIS,ADENOCARCINOMA]
+∞
12.2
12
*
352
Kela drug reimbursment
Abiraterone and enzalutamide
+∞
12.2
12
*
AA049
NOMESCO Finland
Radiotherapy of metasthasis in the brain
+∞
12.2
12
*
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
+∞
12.2
12
*
C32.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of larynx
+∞
12.2
12
*
C18.41
ICD-10 Finland
Malignant tumor of the transverse colon invasive carcinoma
+∞
12.2
12
*
WB101
NOMESCO Finland
Simple cytostatic neoadjuvant therapy
+∞
12.2
12
*
C34.26
ICD-10 Finland
Malignant tumor of the middle lobe, bronchus or lung microcellular carcinoma
+∞
12.2
12
*
XW1AT
NOMESCO Finland
Biopsy from other organ close to skin with ultrasound quidance
7.1
12.1
29
38
I31.3
ICD-10 Finland
Pericardial effusion (noninflammatory)
5.9
12.1
33
52
R74.8
ICD-10 Finland
Abnormal levels of other serum enzymes
1.9
12.1
174
864
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
0.6
12.1
160
2535
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
0.7
12.1
318
4340
GAC01
NOMESCO Finland
Endoscopic biopsy of pleura
8.4
12.1
26
29
WW200
NOMESCO Finland
Immunization
2.3
12.0
109
444
XJD02
NOMESCO Finland
Peroral endoscopic ultrasonography
4.5
12.0
42
88
JN1BD
NOMESCO Finland
Extensive CT examination of upper part of abdomen
4.3
12.0
44
97
M17.9
ICD-10 Finland
Gonarthrosis, unspecified
0.6
11.8
255
3624
J85.2
ICD-10 Finland
Abscess of lung without pneumonia
8.1
11.8
26
30
Z08.8
ICD-10 Finland
Follow-up examination after other treatment for malignant neoplasm
35.1
11.8
15
*
SAB01
NOMESCO Finland
Restricted oral and dental health check by dental hygienist or dental assistant
0.5
11.7
96
1738
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
2.0
11.7
155
746
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
1.5
11.7
396
2506
Z00.0
ICD-10 Finland
General medical examination
0.7
11.7
481
6078
P01AB01
ATC
metronidazole; oral, rectal
1.2
11.7
1588
12528
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
1.7
11.6
241
1345
UDQ22
NOMESCO Finland
Microlaryngoscopy
4.0
11.6
46
109
C10AA01
ATC
simvastatin; oral
0.8
11.6
2214
23253
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
0.7
11.6
321
4340
KEB00
NOMESCO Finland
Biopsy of prostate
3.4
11.5
55
152
Z08.1
ICD-10 Finland
Follow-up examination after radiotherapy for malignant neoplasm
43.6
11.5
14
*
PJD44
NOMESCO Finland
Excision of iliac lymph nodes
43.6
11.5
14
*
A02BX02
ATC
sucralfate; oral
1.7
11.3
235
1313
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
2.8
11.3
70
231
H61.2
ICD-10 Finland
Impacted cerumen
0.5
11.3
97
1729
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
4.6
11.3
38
77
JN5KR
NOMESCO Finland
Very extensive PET-CT of upper body metabolism (eyebrows to thighs)
60.7
11.2
13
*
JJ3AT
NOMESCO Finland
Cytology of liver with ultrasound guidance
60.7
11.2
13
*
HAE00
NOMESCO Finland
Reconstruction of breast using prosthesis
60.7
11.2
13
*
S27.0
ICD-10 Finland
Traumatic pneumothorax
3.2
11.2
57
166
M79.6
ICD-10 Finland
Pain in limb
0.8
11.2
1060
11973
C81.1
ICD-10 Finland
Nodular sclerosis classical Hodgkin lymphoma
+∞
11.2
11
*
WC125
NOMESCO Finland
Demanding cytostatic therapy of local tumor recidive
+∞
11.2
11
*
1XC18
NOMESCO Finland
NA
+∞
11.2
11
*
1850A
ICD-9 Finland
Malignant neoplasm of prostate[NEOPLASMA MALIGNUM PROSTATAE]
+∞
11.2
11
*
8720/3-C44.6
ICD-O-3
Malignant melanoma, NOS, of skin of upper limb and shoulder
+∞
11.2
11
*
C18.99
ICD-10 Finland
Malignant tumor in unspecified location in the colon other or unspecified histology
+∞
11.2
11
*
1624A
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Middle lobe, bronchus or lung[NEOPL MAL LOBI MEDII PULMONIS,CA EPIDERMOIDES]
+∞
11.2
11
*
C67.1
ICD-10 Finland
Malignant neoplasm: Dome of bladder
+∞
11.2
11
*
C18.31
ICD-10 Finland
Malignant tumor of flexura hepatica invasive carcinoma
+∞
11.2
11
*
8249/3-C34.1
ICD-O-3
Neuroendocrine tumor, grade 2 of upper lobe, lung
+∞
11.2
11
*
C39.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of respiratory and intrathoracic organs
+∞
11.2
11
*
C50.92
ICD-10 Finland
Malignant tumor in another specified localization in lobular gland, lobular tumor
+∞
11.2
11
*
L02BB01
ATC
flutamide; oral
+∞
11.2
11
*
1625X
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Lower lobe, bronchus or lung[NEOPL MAL LOBI INFERIORIS PULMONIS,EI HIST/SYTOL DG]
+∞
11.2
11
*
L02BX03
ATC
abiraterone; oral
+∞
11.2
11
*
C43.12
ICD-10 Finland
Malignant melanoma of eyelids including corner of eye: 'superficial spreading' type
+∞
11.2
11
*
C71.10
ICD-10 Finland
Malignant tumor in frontal lobe without histology
+∞
11.2
11
*
192
Kela drug reimbursment
Fulvestrant
+∞
11.2
11
*
K62.7
ICD-10 Finland
Radiation proctitis
+∞
11.2
11
*
C80.90
ICD-10 Finland
Malignant tumor without specified localization without histology
+∞
11.2
11
*
C78.8
ICD-10 Finland
Secondary malignant neoplasm of other and unspecified digestive organs
+∞
11.2
11
*
8090/3-C44.6
ICD-O-3
Basal cell carcinoma, NOS, of skin of upper limb and shoulder
+∞
11.2
11
*
8230/3-C34.1
ICD-O-3
Solid carcinoma, NOS, of upper lobe, lung
+∞
11.2
11
*
SPAT1292
SPAT
Other function in accordance with SHToL (Finnish classification of nursing interventions)
0.6
11.1
217
3148
HAE99
NOMESCO Finland
Other reconstruction of breast
21.4
11.1
16
7
ZXA05
NOMESCO Finland
Left side
1.3
11.1
1269
9795
Z85.3
ICD-10 Finland
Personal history of malignant neoplasm of breast
112.1
11.1
12
*
KC1GB
NOMESCO Finland
Cystography with X-ray
11.7
11.1
20
16
QAE99
NOMESCO Finland
Other excision or repair surgery of skin and subcutaneous tissue in head and neck
2.9
11.0
65
209
J45.9
ICD-10 Finland
Asthma, unspecified
1.3
11.0
801
5819
103
Kela drug reimbursment
Diabetes, insulin-treated
0.8
11.0
1125
12611
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
0.8
11.0
1384
15167
R03AC13
ATC
formoterol; inhalant
1.6
11.0
260
1509
N05BA06
ATC
lorazepam; systemic, sublingual
1.6
11.0
253
1458
GAC97
NOMESCO Finland
Other endoscopic operation on pleura
6.4
10.9
28
41
Z57.2
ICD-10 Finland
Occupational exposure to dust
4.4
10.9
39
84
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
6.0
10.8
29
45
D44.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Adrenal gland
3.3
10.7
53
151
J01DA06
ATC
[U] cefuroxime; systemic
1.4
10.7
611
4272
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
0.8
10.7
1412
15412
M16.1
ICD-10 Finland
Other primary coxarthrosis
0.7
10.7
335
4434
M25.5
ICD-10 Finland
Pain in joint
0.8
10.7
678
8053
NK6CT
NOMESCO Finland
Bone biopsy with CT guidance
8.9
10.7
22
23
M19.0
ICD-10 Finland
Primary arthrosis of other joints
0.6
10.7
190
2809
F00.20*G30.8
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms
0.3
10.6
22
682
D14.3
ICD-10 Finland
Benign neoplasm: Bronchus and lung
5.4
10.6
31
54
N07BC02
ATC
methadone; systemic
7.1
10.5
25
33
FPE20
NOMESCO Finland
Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes
0.5
10.5
86
1557
207
Kela drug reimbursment
Chronic arrhythmias
0.7
10.4
575
6960
C09AA02
ATC
enalapril; systemic
0.8
10.4
862
9901
SFA00
NOMESCO Finland
Small filling
0.6
10.4
225
3192
P17
ICPC
Tobacco abuse
3.0
10.4
59
184
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
1.8
10.3
178
939
PD3YT
NOMESCO Finland
Pelvic artery PTA with stent
2.5
10.3
78
292
K78
ICPC
Atrial fibrillation/flutter
0.7
10.3
238
3331
C43.59
ICD-10 Finland
Malignant melanoma of the trunk other or unspecified histology
56.0
10.3
12
*
C44.42
ICD-10 Finland
Spinocellular carcinoma of the skin of the scalp and neck
56.0
10.3
12
*
J43.2
ICD-10 Finland
Centrilobular emphysema
5.0
10.3
32
60
R01AD12
ATC
fluticasone furoate; nasal
0.7
10.2
575
6944
C03CA01
ATC
furosemide; systemic
1.2
10.1
1964
16032
8500/3-C50.2
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast
+∞
10.1
10
*
C79.0
ICD-10 Finland
Secondary malignant neoplasm of kidney and renal pelvis
+∞
10.1
10
*
8560/3-C34.3
ICD-O-3
Adenosquamous carcinoma of lower lobe, lung
+∞
10.1
10
*
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
+∞
10.1
10
*
8246/3-C34.9
ICD-O-3
Neuroendocrine carcinoma, NOS, of lung, NOS
+∞
10.1
10
*
8070/3-C44.7
ICD-O-3
Squamous cell carcinoma, NOS, of skin of lower limb and hip
+∞
10.1
10
*
8070/3-C34.8
ICD-O-3
Squamous cell carcinoma, NOS, of overlapping lesion of lung
+∞
10.1
10
*
HA013
NOMESCO Finland
Radiotherapy after total ablation of mammary gland
+∞
10.1
10
*
C71.99
ICD-10 Finland
Malignant tumor in unspecified localization in the brain other or unspecified histology
+∞
10.1
10
*
17402
ICD-8 Finland
Malignant neoplasm of breast, Glandulae
+∞
10.1
10
*
C50.19
ICD-10 Finland
Malignant tumor of the central part of the mammary gland, other or undeterminated histology
+∞
10.1
10
*
C44.22
ICD-10 Finland
Spinocellular carcinoma of the skin of the outer ear and the outer ear canal
+∞
10.1
10
*
C01
ICD-10 Finland
Malignant neoplasm of base of tongue
+∞
10.1
10
*
C18.61
ICD-10 Finland
Malignant tumor of the colon descending invasive carcinoma
+∞
10.1
10
*
PJD51
NOMESCO Finland
Block dissection of cervical lymph nodes
+∞
10.1
10
*
8020/3-C34.1
ICD-O-3
Carcinoma, undifferentiated, NOS, of upper lobe, lung
+∞
10.1
10
*
C65
ICD-10 Finland
Malignant neoplasm of renal pelvis
+∞
10.1
10
*
C67
ICD-10 Finland
Malignant neoplasm of bladder
+∞
10.1
10
*
1623E
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Upper lobe, bronchus or lung[NEOPL MAL LOB SUPER PULMONIS,CA ALIA DEF/NUD]
+∞
10.1
10
*
C73.90
ICD-10 Finland
Malignant tumor of the thyroid gland (thyroid gland) without histology
+∞
10.1
10
*
8260/3-C64.9
ICD-O-3
Papillary adenocarcinoma, NOS, of kidney, NOS
+∞
10.1
10
*
GBA35
NOMESCO Finland
Endoscopic insertion of stent into trachea
+∞
10.1
10
*
JGB06
NOMESCO Finland
Partial proctectomy with total excision of mesorectum
+∞
10.1
10
*
C43.52
ICD-10 Finland
Malignant melanoma on the torso: 'superficial spreading' type
+∞
10.1
10
*
8246/3-C34.1
ICD-O-3
Neuroendocrine carcinoma, NOS, of upper lobe, lung
+∞
10.1
10
*
8720/3-C44.7
ICD-O-3
Malignant melanoma, NOS, of skin of lower limb and hip
+∞
10.1
10
*
8013/3-C34.1
ICD-O-3
Large cell neuroendocrine carcinoma of upper lobe, lung
+∞
10.1
10
*
L02BB04
ATC
enzalutamide; oral
+∞
10.1
10
*
R03AC12
ATC
salmeterol; inhalant
1.6
10.1
276
1660
DQE00
NOMESCO Finland
Implantation of prosthetic replacement for larynx
102.7
10.1
11
*
C15.9
ICD-10 Finland
Malignant neoplasm: Oesophagus, unspecified
102.7
10.1
11
*
WC105
NOMESCO Finland
Simple cytostatic therapy of local tumor recidive
102.7
10.1
11
*
SDA04
NOMESCO Finland
Very demanding parodonthologic therapy
0.7
10.1
487
6011
DQB10
NOMESCO Finland
Endoscopic excision of lesion of larynx
3.2
10.1
52
154
S02.51
ICD-10 Finland
Fracture of tooth, open
0.6
10.0
153
2343
M87.1
ICD-10 Finland
Osteonecrosis due to drugs
13.2
10.0
17
12
T90
ICPC
Diabetes non-insulin dependent
0.8
10.0
825
9489
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
3.0
10.0
57
178
HMAK
NOMESCO Finland
NA
0.6
10.0
189
2756
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
0.7
10.0
280
3779
E83.50
ICD-10 Finland
Hypercalcemia
2.9
9.9
58
186
WVC10
NOMESCO Finland
Subcutaneous infusion of drugs
15.0
9.9
16
10
Z46.1
ICD-10 Finland
Fitting and adjustment of hearing aid
0.6
9.9
183
2683
G04CB02
ATC
dutasteride; oral
0.7
9.9
227
3183
J98.4
ICD-10 Finland
Other disorders of lung
6.1
9.9
26
40
J18.0
ICD-10 Finland
Bronchopneumonia, unspecified
2.0
9.8
114
524
XX9BW
NOMESCO Finland
Submitting image material and/or investigation material to authority or other institution
3.4
9.8
46
127
B01AF02
ATC
apixaban; oral
0.7
9.8
280
3765
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
2.3
9.8
86
349
F00.10
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
0.2
9.8
11
468
JFB31
NOMESCO Finland
Laparoscopic right hemicolectomy
5.5
9.7
28
48
OAA67
SPAT
NA
0.3
9.7
21
636
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
0.8
9.7
1043
11649
PJD42
NOMESCO Finland
Excision of axillary lymph nodes
8.2
9.7
21
24
I49.3
ICD-10 Finland
Ventricular premature depolarization
0.6
9.7
123
1974
QBC00
NOMESCO Finland
Removal of foreign body from skin of trunk or subcutaneous tissue
12.2
9.7
17
13
N87
ICPC
Parkinsonism
0.2
9.7
9
430
R05FB02
ATC
cough suppressants and expectorants
1.2
9.7
1906
15571
JN4ED
NOMESCO Finland
Body CT examination with specail preparation
37.3
9.6
12
*
K86
ICPC
Hypertension uncomplicated
0.7
9.6
330
4299
N40
ICD-10 Finland
Hyperplasia of prostate
0.8
9.6
1136
12562
XW3AT
NOMESCO Finland
Biopsy of other superficial organ with ultrasound guidance
6.9
9.6
23
31
R81
ICPC
Pneumonia
1.8
9.5
166
883
G04BD12
ATC
mirabegron; oral
0.7
9.5
231
3204
GWW96
NOMESCO Finland
Other reoperation in thoracic surgery
15.6
9.5
15
9
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
2.0
9.5
122
584
K80
ICPC
Cardiac arrhythmia NOS
0.6
9.4
138
2136
J93.0
ICD-10 Finland
Spontaneous tension pneumothorax
5.2
9.4
28
50
D01BA02
ATC
terbinafine; oral; topical
0.8
9.4
779
8964
C44.52
ICD-10 Finland
Spinocellular carcinoma of the skin on the torso
18.7
9.4
14
7
Z45.0
ICD-10 Finland
Adjustment and management of cardiac devices
0.5
9.4
91
1568
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
0.6
9.4
131
2050
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
0.8
9.4
558
6688
C44.72
ICD-10 Finland
Spinocellular carcinoma of the skin of the lower extremity including the hip
51.4
9.3
11
*
R03BA02
ATC
budesonide; inhalant
1.3
9.3
736
5402
SPAT1324
SPAT
Screening procedure
0.6
9.3
139
2141
J91
ICD-10 Finland
Pleural effusion in conditions classified elsewhere
9.9
9.3
18
17
ZZA50
NOMESCO Finland
Full thickness skin graft
9.9
9.3
18
17
PJD45
NOMESCO Finland
Excision of inguinal lymph nodes
9.9
9.3
18
17
RS220
NOMESCO Finland
NA
3.0
9.3
53
166
OAB44
SPAT
NA
0.3
9.3
25
680
J94.9
ICD-10 Finland
Pleural condition, unspecified
3.7
9.3
39
99
JFG10
NOMESCO Finland
Closure of loop colostomy without resection
5.8
9.2
25
40
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
0.6
9.2
129
2015
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.2
9.1
1347
10673
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
0.8
9.1
693
8058
HA1TE
NOMESCO Finland
Supplementary or limited ultrasound examination of mammary glands
6.9
9.1
22
30
C18.72
ICD-10 Finland
Malignant tumor of sigmoid carcinoma of adenoma
93.4
9.1
10
*
Z85.1
ICD-10 Finland
Personal history of malignant neoplasm of trachea, bronchus and lung
93.4
9.1
10
*
C18.7
ICD-10 Finland
Malignant neoplasm: Sigmoid colon
+∞
9.1
9
*
8070/3-C15.9
ICD-O-3
Squamous cell carcinoma, NOS, of esophagus, NOS
+∞
9.1
9
*
OAA41
NOMESCO Finland
Health check based on individual needs
+∞
9.1
9
*
C77.5
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrapelvic lymph nodes
+∞
9.1
9
*
8140/3-C19.9
ICD-O-3
Adenocarcinoma, NOS, of rectosigmoid junction
+∞
9.1
9
*
C18.09
ICD-10 Finland
Malignant tumor of caecum other or unspecified histology
+∞
9.1
9
*
8550/3-C34.3
ICD-O-3
Acinar cell carcinoma of lower lobe, lung
+∞
9.1
9
*
WB223
NOMESCO Finland
Demanding adjuvant hormone therapy of malignancy
+∞
9.1
9
*
C69.30
ICD-10 Finland
Malignant tumor of the chorioidea without histology
+∞
9.1
9
*
8020/3-C34.9
ICD-O-3
Carcinoma, undifferentiated, NOS, of lung, NOS
+∞
9.1
9
*
8560/3-C34.1
ICD-O-3
Adenosquamous carcinoma of upper lobe, lung
+∞
9.1
9
*
C18.40
ICD-10 Finland
Malignant tumor of the transverse colon without histology
+∞
9.1
9
*
C04.0
ICD-10 Finland
Malignant neoplasm: Anterior floor of mouth
+∞
9.1
9
*
C56.71
ICD-10 Finland
Serous epithelial malignant tumor of the ovary
+∞
9.1
9
*
5BX04
NOMESCO Finland
NA
+∞
9.1
9
*
8140/3-C18.9
ICD-O-3
Adenocarcinoma, NOS, of colon, NOS
+∞
9.1
9
*
L02BA03
ATC
fulvestrant; parenteral
+∞
9.1
9
*
C18.79
ICD-10 Finland
Malignant tumor of the sigmoid or other unspecified histology
+∞
9.1
9
*
8070/3-C32.0
ICD-O-3
Squamous cell carcinoma, NOS, of glottis
+∞
9.1
9
*
8140/3-C16.9
ICD-O-3
Adenocarcinoma, NOS, of stomach, NOS
+∞
9.1
9
*
8070/3-C44.2
ICD-O-3
Squamous cell carcinoma, NOS, of external ear
+∞
9.1
9
*
L01EB02
ATC
erlotinib; oral (epidermal growth factor receptor (egfr) tyrosine kinase inhibitors)
+∞
9.1
9
*
8140/3-C18.0
ICD-O-3
Adenocarcinoma, NOS, of cecum
+∞
9.1
9
*
8140/3-C16.0
ICD-O-3
Adenocarcinoma, NOS, of cardia, NOS
+∞
9.1
9
*
C73
ICD-10 Finland
Malignant neoplasm of thyroid gland
+∞
9.1
9
*
JCC12
NOMESCO Finland
Thoracoscopic or laparoscopic partial oesophagectomy
+∞
9.1
9
*
C50.89
ICD-10 Finland
Overall malignant tumor of the mammary gland, other or undeterminated histology
+∞
9.1
9
*
HAD60
NOMESCO Finland
Replacement of prosthetic implant in breast
+∞
9.1
9
*
SDE02
NOMESCO Finland
Periodontal treatment by dental hygienist
0.8
9.1
532
6396
J86.00
ICD-10 Finland
Empyema with broncho-pleural fistula
7.3
9.1
21
27
JN7AQ
NOMESCO Finland
Somatostatin receptor SPET med low dose CT
28.0
9.1
12
*
J45.1
ICD-10 Finland
Nonallergic asthma
1.5
9.1
309
1959
C08CA13
ATC
lercanidipine; oral
0.7
9.1
386
4857
M70.6
ICD-10 Finland
Trochanteric bursitis
0.7
9.0
243
3303
H01CB02
ATC
octreotide; parenteral
16.3
9.0
14
8
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
1.9
8.9
132
664
J37.0
ICD-10 Finland
Chronic laryngitis
1.9
8.9
128
637
I50.9
ICD-10 Finland
Heart failure, unspecified
0.8
8.9
661
7705
I87.1
ICD-10 Finland
Compression of vein
9.9
8.8
17
16
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
2.8
8.8
56
190
Z97.4
ICD-10 Finland
Presence of external hearing-aid
0.6
8.8
116
1842
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
0.8
8.8
1467
15713
YX8AD
NOMESCO Finland
Stereotactic CT examination for dose design of radiotherapy
12.7
8.8
15
11
Z01.1
ICD-10 Finland
Examination of ears and hearing
0.7
8.8
370
4661
S12
ICPC
Insect bite/sting
0.6
8.8
152
2261
R00.1
ICD-10 Finland
Bradycardia, unspecified
0.5
8.7
68
1247
DQA10
NOMESCO Finland
Biopsy of larynx
4.8
8.7
28
55
H81.1
ICD-10 Finland
Benign paroxysmal vertigo
0.6
8.7
191
2703
SPAT1260
SPAT
Consultation of another employee
0.8
8.7
496
5984
A10BK01
ATC
dapagliflozin; oral
0.5
8.7
53
1052
A10BA02
ATC
metformin; oral
0.8
8.7
1183
12918
I50.1
ICD-10 Finland
Left ventricular failure
0.6
8.7
167
2424
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
3.2
8.7
43
125
G56.0
ICD-10 Finland
Carpal tunnel syndrome
0.7
8.6
273
3609
J96.1
ICD-10 Finland
Chronic respiratory failure
1.7
8.6
161
874
G91.2
ICD-10 Finland
Normal-pressure hydrocephalus
0.3
8.6
13
469
WPA10
NOMESCO Finland
Proactive palliative care treatment plan
22.4
8.6
12
5
N81.6
ICD-10 Finland
Rectocele
0.5
8.6
77
1351
GCA08
NOMESCO Finland
Bronchoscopic excsion of lesion of bronchus
17.3
8.6
13
7
ZXC20
NOMESCO Finland
Use of chemical agents
2.5
8.6
63
234
4859X
ICD-9 Finland
Bronchopneumonia, organism unspecified[PNEUMONIA NUD]
1.8
8.6
144
756
I31.9
ICD-10 Finland
Disease of pericardium, unspecified
3.2
8.6
43
126
SPAT1305
SPAT
Counselling and guidance related to physical exercise
0.7
8.6
216
2972
F17.20
ICD-10 Finland
Addiction relationship caused by tobacco addiction relationship currently independent
3.6
8.5
37
97
R02
ICPC
Shortness of breath/dyspnoea
1.3
8.5
544
3873
D48.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified
2.5
8.5
65
246
DFF00
NOMESCO Finland
Pure tone audiometry
0.7
8.4
208
2873
GAC36
NOMESCO Finland
Chemical pleurodesis
46.7
8.4
10
*
S46.0
ICD-10 Finland
Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder
0.7
8.4
198
2758
WGA11
NOMESCO Finland
Planning of pain management
10.0
8.4
16
15
J85.1
ICD-10 Finland
Abscess of lung with pneumonia
6.3
8.3
21
31
JN5ER
NOMESCO Finland
PET-CT of receptors in whole body
13.1
8.3
14
10
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
2.7
8.3
53
181
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
3.9
8.3
32
76
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
1.8
8.3
138
727
R03AL05
ATC
formoterol and aclidinium bromide; inhalant
4.3
8.2
29
63
R2110
NOMESCO Finland
Giving the first information
1.6
8.2
229
1388
R05
ICD-10 Finland
Cough
1.3
8.2
793
5981
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
2.0
8.2
95
438
L01AA02
ATC
chlorambucil; oral
15.2
8.2
13
8
NK6AQ
NOMESCO Finland
Whole body bone SPET with low dose CT
15.2
8.2
13
8
H40.0
ICD-10 Finland
Glaucoma suspect
0.6
8.2
160
2317
SPAT1263
SPAT
Sampling
0.8
8.2
1476
15722
9732/3-C42.1
ICD-O-3
Plasma cell myeloma of bone marrow
25.7
8.2
11
*
I35.1
ICD-10 Finland
Aortic (valve) insufficiency
0.6
8.2
119
1840
BC1CD
NOMESCO Finland
Very extensive CT of adrenal glands
4.8
8.2
26
51
XX9AN
NOMESCO Finland
Complementary isotope examination or additional picture
84.1
8.2
9
*
C15.4
ICD-10 Finland
Malignant neoplasm: Middle third of oesophagus
84.1
8.2
9
*
GDA96
NOMESCO Finland
Other incision, excision of lesion or repair of lung
84.1
8.2
9
*
C50.82
ICD-10 Finland
Overall malignant tumor of the mammary gland, lobular tumor
84.1
8.2
9
*
JCW98
NOMESCO Finland
Other transluminal endoscopic procedure on oesophagus
18.7
8.1
12
6
5702
FHL
Local lymph node removal (eg armpit, groin)
18.7
8.1
12
6
JFA98
NOMESCO Finland
Other transluminal endoscopic local operation on intestine
2.2
8.1
78
332
SDE03
NOMESCO Finland
Periodontal treatment by dental hygienist, extensive
0.8
8.1
549
6480
GAC46
NOMESCO Finland
Partial decortication of pleura
7.6
8.1
18
22
ZZR10
NOMESCO Finland
Flap of skin and muscle
7.6
8.1
18
22
8070/3-C00.1
ICD-O-3
Squamous cell carcinoma, NOS, of external lower lip
+∞
8.1
8
*
J70.1
ICD-10 Finland
Chronic and other pulmonary manifestations due to radiation
+∞
8.1
8
*
C66
ICD-10 Finland
Malignant neoplasm of ureter
+∞
8.1
8
*
C83.39
ICD-10 Finland
Diffuse non-Hodgkin's large cell lymphoma UNS
+∞
8.1
8
*
C18.9
ICD-10 Finland
Malignant neoplasm: Colon, unspecified
+∞
8.1
8
*
C09.9
ICD-10 Finland
Malignant neoplasm: Tonsil, unspecified
+∞
8.1
8
*
GD3CT
NOMESCO Finland
Labeling lungs with CT guidance
+∞
8.1
8
*
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
+∞
8.1
8
*
C16.00
ICD-10 Finland
Cardia
+∞
8.1
8
*
C43.99
ICD-10 Finland
Unspecified localization of malignant melanoma of the skin other or unspecified histology
+∞
8.1
8
*
WD215
NOMESCO Finland
Multiple therapy of methastized malignancy with hormones
+∞
8.1
8
*
WB303
NOMESCO Finland
Simple adjuvant therapy of malignancy with biomodifiers
+∞
8.1
8
*
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
+∞
8.1
8
*
C25.2
ICD-10 Finland
Malignant neoplasm: Tail of pancreas
+∞
8.1
8
*
GDC23
NOMESCO Finland
Lobectomy and segment resection of lung
+∞
8.1
8
*
WB133
NOMESCO Finland
Very demanding adjuvant cytostatic therapy
+∞
8.1
8
*
C00.1
ICD-10 Finland
Malignant neoplasm: External lower lip
+∞
8.1
8
*
C34.24
ICD-10 Finland
Malignant tumor of the middle lobe, bronchus or lung macrocellular anaplastic carcinoma
+∞
8.1
8
*
C17.0
ICD-10 Finland
Malignant neoplasm: Duodenum
+∞
8.1
8
*
8140/3-C18.6
ICD-O-3
Adenocarcinoma, NOS, of descending colon
+∞
8.1
8
*
L01ED01
ATC
crizotinib; oral
+∞
8.1
8
*
8013/3-C34.3
ICD-O-3
Large cell neuroendocrine carcinoma of lower lobe, lung
+∞
8.1
8
*
8500/3-C50.5
ICD-O-3
Infiltrating duct carcinoma, NOS, of lower-outer quadrant of breast
+∞
8.1
8
*
8070/3-C09.9
ICD-O-3
Squamous cell carcinoma, NOS, of tonsil, NOS
+∞
8.1
8
*
8071/3-C34.1
ICD-O-3
Squamous cell carcinoma, keratinizing, NOS, of upper lobe, lung
+∞
8.1
8
*
8140/3-C18.4
ICD-O-3
Adenocarcinoma, NOS, of transverse colon
+∞
8.1
8
*
1623F
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Upper lobe, bronchus or lung[NEOPL MAL LOB SUPER PULMONIS,MUU HISTOLOGIA]
+∞
8.1
8
*
8072/3-C34.3
ICD-O-3
Squamous cell carcinoma, large cell, nonkeratinizing, NOS, of lower lobe, lung
+∞
8.1
8
*
C43.39
ICD-10 Finland
Malignant melanoma of another or unspecified part of the face other or unspecified histology
+∞
8.1
8
*
C19
ICD-10 Finland
Malignant neoplasm of rectosigmoid junction
+∞
8.1
8
*
C50.29
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland, other or undeterminated histology
+∞
8.1
8
*
8140/3-C18.3
ICD-O-3
Adenocarcinoma, NOS, of hepatic flexure of colon
+∞
8.1
8
*
8260/3-C34.1
ICD-O-3
Papillary adenocarcinoma, NOS, of upper lobe, lung
+∞
8.1
8
*
C43.70
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip without histology
+∞
8.1
8
*
C77.3
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Axillary and upper limb lymph nodes
+∞
8.1
8
*
1440
FHL
Mediastinoscopy
9.3
8.1
16
16
FNA01
NOMESCO Finland
Anastomosis to coronary artery from internal mammary artery, one distal anastamosis
0.6
8.1
171
2434
-1
NOMESCO Finland
NA
0.8
8.1
781
8839
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.4
8.1
448
3121
R03BB02
ATC
oxitropium bromide; inhalant
2.3
8.0
71
289
F06.7
ICD-10 Finland
Mild cognitive disorder
0.4
8.0
42
875
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
0.8
8.0
451
5448
N81.1
ICD-10 Finland
Cystocele
0.5
8.0
83
1395
U07
ICPC
Urine symptom/complaint other
0.6
8.0
94
1530
D40.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Prostate
2.6
8.0
58
213
J45.8
ICD-10 Finland
Mixed asthma
1.8
7.9
133
699
R03AC19
ATC
olodaterol; inhalant
3.7
7.9
33
84
SGA01
NOMESCO Finland
Tooth opening as first aid
0.7
7.9
224
3016
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
3.1
7.9
40
119
I26.0
ICD-10 Finland
Pulmonary embolism with mention of acute cor pulmonale
1.9
7.8
103
500
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
2.7
7.8
51
178
D09.0
ICD-10 Finland
Carcinoma in situ: Bladder
31.1
7.8
10
*
GA3CT
NOMESCO Finland
Pleural cytology with CT guidance
31.1
7.8
10
*
HWA00
NOMESCO Finland
Repair of wound dehiscence in surgery of mammary gland
31.1
7.8
10
*
R92
ICPC
Neoplasm respiratory unspecified
31.1
7.8
10
*
4912A
ICD-9 Finland
Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS CHRONICA OBSTRUCTIVA]
2.5
7.8
58
218
JL5AG
NOMESCO Finland
Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet
3.2
7.8
38
110
SGB10
NOMESCO Finland
Fiiling of rooth of tooth with one root channel
0.7
7.8
239
3170
TQW20
NOMESCO Finland
Tatoe
16.0
7.8
12
7
A10BJ06
ATC
semaglutide; parenteral
0.4
7.7
25
631
M15.9
ICD-10 Finland
Polyarthrosis, unspecified
0.6
7.7
95
1530
AXX01
SPAT
NA
0.2
7.7
9
376
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
0.7
7.7
386
4740
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
2.1
7.7
82
367
ZXH06
SPAT
NA
0.3
7.7
20
554
TKC20
NOMESCO Finland
Catheterisation of bladder
1.4
7.6
358
2421
FPE00
NOMESCO Finland
Implantation of transvenous cardiac pacemaker with ventricular electrode
0.4
7.6
41
847
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
0.7
7.6
167
2360
M01AC06
ATC
meloxicam; systemic, rectal
0.8
7.6
1194
12889
M54.5
ICD-10 Finland
Low back pain
0.8
7.5
886
9834
XW4AT
NOMESCO Finland
Biopsy of other inner organ with ultrasound guidance
12.1
7.5
13
10
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
1.5
7.5
248
1564
R03AC18
ATC
indacaterol; inhalant
2.4
7.5
60
235
A06AC01
ATC
ispaghula (psylla seeds); oral
0.8
7.5
765
8613
R42
ICD-10 Finland
Dizziness and giddiness
0.8
7.5
735
8309
C44.10
ICD-10 Finland
Malignant tumor of the skin of the eyelids including the corner of the eye without histology
42.0
7.5
9
*
GBA28
NOMESCO Finland
Endoscopic laser therapy of lesion of trachea
42.0
7.5
9
*
C44.3
ICD-10 Finland
Malignant neoplasm: Skin of other and unspecified parts of face
42.0
7.5
9
*
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.2
7.5
1123
8898
SPAT1290
SPAT
Preparation of deceased person
7.2
7.4
17
22
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
0.8
7.4
1091
11853
WZC00
SPAT
NA
0.5
7.4
46
905
I20.01
ICD-10 Finland
Unstable angina
0.5
7.4
76
1283
D43.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, unspecified
14.0
7.4
12
8
N81.2
ICD-10 Finland
Incomplete uterovaginal prolapse
0.5
7.3
49
937
D75
ICPC
Malignant neoplasm colon/rectum
17.1
7.3
11
6
C44.62
ICD-10 Finland
Spinocellular carcinoma of the skin of the upper extremity including the shoulder
23.3
7.3
10
*
M16.0
ICD-10 Finland
Primary coxarthrosis, bilateral
0.7
7.3
179
2474
C09CA06
ATC
candesartan; oral
0.8
7.2
612
7040
YJ1BD
NOMESCO Finland
Extensive CT examination of abdomen for dose design of radiotherapy
74.8
7.2
8
*
D70.89
ICD-10 Finland
Neutropenic splenomegaly
3.0
7.2
38
117
D43.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Central nervous system, unspecified
7.5
7.2
16
20
I49.5
ICD-10 Finland
Sick sinus syndrome
0.6
7.2
86
1394
DFF15
NOMESCO Finland
Speech audiometry
0.6
7.2
88
1416
DAB00
NOMESCO Finland
Excision of lesion of auricle
3.5
7.2
31
82
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
0.8
7.2
777
8695
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
0.7
7.2
260
3356
D48.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other specified sites
3.4
7.2
33
92
I34.09
ICD-10 Finland
Mitral (valve) insufficiency
0.6
7.1
83
1355
ZXC10
NOMESCO Finland
Use of laser
2.0
7.1
83
386
SPAT1111
SPAT
Planning of analgesia
2.5
7.1
53
198
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
0.5
7.1
64
1120
H81
ICPC
Excessive ear wax
0.8
7.1
553
6420
DQB30
NOMESCO Finland
Laryngectomy
+∞
7.1
7
*
HAE05
NOMESCO Finland
Reconstruction of breast using soft tissue and prosthesis
+∞
7.1
7
*
PJD53
NOMESCO Finland
Block dissection of aortic lymph nodes
+∞
7.1
7
*
8070/3-C01.9
ICD-O-3
Squamous cell carcinoma, NOS, of base of tongue, NOS
+∞
7.1
7
*
8230/3-C34.3
ICD-O-3
Solid carcinoma, NOS, of lower lobe, lung
+∞
7.1
7
*
8070/3-C44.6
ICD-O-3
Squamous cell carcinoma, NOS, of skin of upper limb and shoulder
+∞
7.1
7
*
C09.0
ICD-10 Finland
Malignant neoplasm: Tonsillar fossa
+∞
7.1
7
*
C79.41
ICD-10 Finland
Secondary malignant tumor of optic nerve and eye
+∞
7.1
7
*
C73.99
ICD-10 Finland
Malignant tumor of the thyroid gland (thyroid gland), other or unspecified histology
+∞
7.1
7
*
C18.60
ICD-10 Finland
Malignant tumor of the descending colon without histology
+∞
7.1
7
*
8072/3-C34.1
ICD-O-3
Squamous cell carcinoma, large cell, nonkeratinizing, NOS, of upper lobe, lung
+∞
7.1
7
*
8260/3-C34.3
ICD-O-3
Papillary adenocarcinoma, NOS, of lower lobe, lung
+∞
7.1
7
*
C05.1
ICD-10 Finland
Malignant neoplasm: Soft palate
+∞
7.1
7
*
C25.1
ICD-10 Finland
Malignant neoplasm: Body of pancreas
+∞
7.1
7
*
GCA40
NOMESCO Finland
Closure of bronchopleural fistula
+∞
7.1
7
*
C50.39
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, other or undeterminated histology
+∞
7.1
7
*
1623B
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Upper lobe, bronchus or lung[NEOPL MAL LOB SUPER PULMONIS,CA MICROCELLURE]
+∞
7.1
7
*
L01XX17
ATC
[U] topotecan; systemic
+∞
7.1
7
*
180
Kela drug reimbursment
Interferon alfa
+∞
7.1
7
*
XX7JT
NOMESCO Finland
Somatostatin isotope ablative therapy
+∞
7.1
7
*
8130/3-C67.9
ICD-O-3
Papillary urothelial carcinoma of bladder, NOS
+∞
7.1
7
*
1890B
ICD-9 Finland
Malignant neoplasm of kidney and other and unspecified urinary organs, Kidney, except pelvis[NEOPL MAL RENIS PELVI EXCEPTO,ADENOCARCINOMA]
+∞
7.1
7
*
8046/3-C34.0
ICD-O-3
Non-small cell carcinoma of main bronchus
+∞
7.1
7
*
HAC25
NOMESCO Finland
Radical mastectomy
+∞
7.1
7
*
C80.0
ICD-10 Finland
Malignant neoplasm, primary site unknown, so stated
+∞
7.1
7
*
C83.1
ICD-10 Finland
Mantle cell lymphoma
+∞
7.1
7
*
C76.8
ICD-10 Finland
Malignant neoplasm of other and ill-defined sites: Overlapping lesion of other and ill-defined sites
+∞
7.1
7
*
8020/3-C34.3
ICD-O-3
Carcinoma, undifferentiated, NOS, of lower lobe, lung
+∞
7.1
7
*
ZX040
NOMESCO Finland
Intracavity HDR radiotherapy
+∞
7.1
7
*
1629C
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Bronchus and lung, unspecified[NEOPL MAL PULMONIS LOCO ALIO/NUD,ADENOCARCINOMA]
+∞
7.1
7
*
1990X
ICD-9 Finland
Malignant neoplasm without specification of site, Disseminated
+∞
7.1
7
*
16212
ICD-8 Finland
Malignant neoplasm of trachea, bronchus and lung, Lobi superioris pulmonis
+∞
7.1
7
*
C79.40
ICD-10 Finland
Secondary malignant tumor of the spinal cord
+∞
7.1
7
*
C80.91
ICD-10 Finland
Malignant tumor without specified localization epidermoid carcinoma
+∞
7.1
7
*
C44.00
ICD-10 Finland
Malignant tumor of the lip skin without histology
+∞
7.1
7
*
C18.91
ICD-10 Finland
Malignant tumor of unspecified location in colon invasive carcinoma
+∞
7.1
7
*
C82.00
ICD-10 Finland
Follicular nodular non-Hodgkin's lymphoma, ungraded
+∞
7.1
7
*
L71
ICPC
Malignant neoplasm musculoskeletal
+∞
7.1
7
*
JN4LR
NOMESCO Finland
Extensive PET-CT of receptors in whole body
+∞
7.1
7
*
8520/3-C50.4
ICD-O-3
Lobular carcinoma, NOS, of upper-outer quadrant of breast
+∞
7.1
7
*
8091/3-C44.9
ICD-O-3
Superficial basal cell carcinoma of skin, NOS
+∞
7.1
7
*
C50.10
ICD-10 Finland
Malignant tumor of the central part of the mammary gland, no histological veryfication
+∞
7.1
7
*
8012/3-C34.9
ICD-O-3
Large cell carcinoma, NOS, of lung, NOS
+∞
7.1
7
*
3017
Kela drug reimbursment
Brigatinib
+∞
7.1
7
*
C18.90
ICD-10 Finland
Malignant tumor in unspecified location in the colon without histology
+∞
7.1
7
*
BA3AT
NOMESCO Finland
Cytology of thyroid with ultrasound quidance
2.6
7.1
50
183
KCD32
NOMESCO Finland
Cystoscopic destruction of tumour of bladder
3.4
7.1
32
88
GAA97
NOMESCO Finland
Other thoracoscopic drainage procedures on pleura
12.5
7.1
12
9
R03BB07
ATC
umeclidinium bromide; inhalant
2.6
7.0
47
168
N04BA03
ATC
levodopa, decarboxylase inhibitor and COMT inhibitor; oral
0.2
7.0
7
322
SFA40
NOMESCO Finland
Replacement of krone of tooth
0.8
7.0
559
6473
M76.6
ICD-10 Finland
Achilles tendinitis
0.5
7.0
52
963
HA1CG
NOMESCO Finland
Extensive MRI examination of mammary gland with high intensity magnet
7.8
6.9
15
18
I87.2
ICD-10 Finland
Venous insufficiency (chronic)(peripheral)
0.7
6.9
220
2899
UKC05
NOMESCO Finland
Cystoscopy and bladder biopsy
3.1
6.9
35
105
D77
ICPC
Malignant digestive neopl other/NOS
28.0
6.9
9
*
EAA30
NOMESCO Finland
Partial excision of lower lip
28.0
6.9
9
*
V03AA01
ATC
NA
2.0
6.9
83
392
D37.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Colon
2.4
6.9
53
205
F17.22
ICD-10 Finland
Addiction-related addiction currently uses controlled substitution treatment
6.4
6.9
17
25
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
2.7
6.9
44
151
I44.1
ICD-10 Finland
Atrioventricular block, second degree
0.5
6.8
40
801
R01AD01
ATC
beclometasone; nasal
0.7
6.8
348
4266
PEH57
NOMESCO Finland
Bypass from femoral artery to popliteal artery below knee
2.2
6.8
63
264
K03.00
ICD-10 Finland
Approximal wear
0.5
6.8
55
994
KAD00
NOMESCO Finland
Partial nephrectomy
6.8
6.8
16
22
R25.1
ICD-10 Finland
Tremor, unspecified
0.5
6.8
42
826
ZZQ00
NOMESCO Finland
Free microvascular graft of skin
11.2
6.8
12
10
A01AB09
ATC
miconazole; local oral
1.4
6.8
368
2558
4402A
ICD-9 Finland
Atherosclerosis, Of native arteries of the extremities
1.8
6.8
110
578
TPW99
NOMESCO Finland
Other minor surgical procedure on peripheral vessel or lymphatic system
2.5
6.7
51
194
W00
ICD-10 Finland
Fall on same level involving ice and snow
0.7
6.7
242
3126
CHD05
NOMESCO Finland
Selective lasertrabeculoplasty
0.5
6.7
40
795
SPAT1304
SPAT
Counselling and guidance related to ageing
0.7
6.7
195
2612
F05.1
ICD-10 Finland
Delirium superimposed on dementia
0.1
6.7
*
232
G62.0
ICD-10 Finland
Drug-induced polyneuropathy
8.2
6.7
14
16
WX111
NOMESCO Finland
Local infiltration anesthesia
0.5
6.7
42
820
I21.9
ICD-10 Finland
Acute myocardial infarction, unspecified
0.5
6.7
67
1139
M72.2
ICD-10 Finland
Plantar fascial fibromatosis
0.6
6.7
96
1487
ZX136
NOMESCO Finland
Intravesicalis
4.0
6.7
25
59
OAB43
SPAT
NA
0.6
6.6
73
1208
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
0.7
6.6
283
3556
ZXF99
NOMESCO Finland
Other r3eason to interrupt procedure
4.1
6.6
24
55
C44
ICD-10 Finland
Other malignant neoplasms of skin
12.8
6.6
11
8
TDA90
SPAT
NA
0.4
6.6
27
615
F17.2
ICD-10 Finland
Mental and behavioural disorders due to use of tobacco, dependence syndrome
3.5
6.6
28
74
K76
ICPC
Ischaemic heart dis without angina
0.5
6.6
51
930
G30
ICD-10 Finland
Alzheimer disease
0.3
6.6
12
390
C44.29
ICD-10 Finland
Malignant tumor of the skin of the outer ear and in the outer ear canal other or unspecified histology
37.3
6.5
8
*
C16.9
ICD-10 Finland
Malignant neoplasm: Stomach, unspecified
37.3
6.5
8
*
D11.0
ICD-10 Finland
Benign neoplasm: Parotid gland
2.0
6.5
78
367
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
0.8
6.5
1206
12861
30310
ICD-8 Finland
Alcoholism, Habitual excessive drinking
2.2
6.5
59
248
JG1CG
NOMESCO Finland
Extensive MRI of rectum
10.2
6.5
12
11
EDB00
NOMESCO Finland
Partial excision of mandible
15.6
6.5
10
6
ZZQ10
NOMESCO Finland
Free microvascular graft of skin and muscle
15.6
6.5
10
6
F17.1
ICD-10 Finland
Mental and behavioural disorders due to use of tobacco, harmful use
7.7
6.5
14
17
L01
ICPC
Neck symptom/complaint
0.7
6.4
278
3492
A21
ICPC
Risk factor for malignancy
21.0
6.4
9
*
GDA97
NOMESCO Finland
Other thoracoscopic incision, excision of lesion or repair of lung
21.0
6.4
9
*
DAB10
NOMESCO Finland
Partial excision of auricle
21.0
6.4
9
*
M54.4
ICD-10 Finland
Lumbago with sciatica
0.8
6.4
364
4394
SPAT1101
SPAT
Orthostatic test
0.6
6.4
107
1599
NBL00
NOMESCO Finland
Suture or reinsertation of rotator cuff of shoulder
0.6
6.4
131
1874
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
0.6
6.4
80
1281
ZX114
NOMESCO Finland
Intramuscular
2.4
6.4
49
189
R03AK04
ATC
salbutamol and sodium cromoglicate; inhalant
2.0
6.4
75
352
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
5.7
6.4
17
28
5010A
ICD-9 Finland
Asbestosis[ASBESTOSIS]
5.7
6.4
17
28
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
2.9
6.4
35
112
K77
ICPC
Heart failure
0.4
6.4
29
636
L16
ICPC
Ankle symptom/complaint
0.7
6.4
193
2563
T84.0
ICD-10 Finland
Mechanical complication of internal joint prosthesis
0.6
6.3
72
1181
ZXC40
NOMESCO Finland
Use of ultrasound
4.1
6.3
23
53
WX725
NOMESCO Finland
Noninvasive ventilation
1.6
6.3
163
973
AN1
HP
Coronary angiography
0.8
6.3
501
5805
G04CA01
ATC
alfuzosin; oral
0.8
6.3
464
5423
R5140
NOMESCO Finland
Monitoring the use of the aid
0.7
6.3
261
3296
XX3AT
NOMESCO Finland
Other labeling with ultrasound guidance
11.4
6.3
11
9
A10AA02
ATC
NA
0.5
6.3
64
1082
M02AA10
ATC
ketoprofen; topical
0.8
6.3
452
5296
E83.4
ICD-10 Finland
Disorders of magnesium metabolism
7.3
6.3
14
18
B01AA03
ATC
warfarin; systemic
0.8
6.2
1071
11495
C50.80
ICD-10 Finland
Overall malignant tumor of the mammary gland, no histological veryfication
65.5
6.2
7
*
S01ED51
ATC
timolol, combinations; ophthalmic
0.7
6.2
219
2838
KAC11
NOMESCO Finland
Total nephrectomy with capsule, transcutaneous
9.3
6.2
12
12
I34.00
ICD-10 Finland
Mitral (valve) incompetence NOS or of specified cause, except rheumatic
0.4
6.2
33
684
NA3BG
SPAT
NA
0.1
6.2
*
221
R03BA01
ATC
beclometasone; inhalant
1.3
6.2
619
4687
K42.9
ICD-10 Finland
Umbilical hernia without obstruction or gangrene
0.6
6.2
75
1208
N02AC04
ATC
dextropropoxyphene; oral
1.5
6.2
226
1464
N04BC04
ATC
ropinirole; oral
0.2
6.2
7
293
I83.9
ICD-10 Finland
Varicose veins of lower extremities without ulcer or inflammation
0.7
6.1
213
2767
D37.08
ICD-10 Finland
Tumor of uncertain or unknown nature in other part of lip, oral cavity and pharynx
6.4
6.1
15
22
R03AC03
ATC
terbutaline; inhalant
1.3
6.1
538
4005
G04CB01
ATC
finasteride; oral (testosterone-5-alpha reductase inhibitors)
0.8
6.1
585
6639
Z08.9
ICD-10 Finland
Follow-up examination after unspecified treatment for malignant neoplasm
13.3
6.1
10
7
A10AD01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
0.4
6.1
29
627
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
0.7
6.1
186
2466
SGA02
NOMESCO Finland
Opening and dilatation of root canal of tooth
0.7
6.1
230
2946
C82.01
ICD-10 Finland
Follicular nodular lymphoma, grade I
+∞
6.1
6
*
8012/3-C34.3
ICD-O-3
Large cell carcinoma, NOS, of lower lobe, lung
+∞
6.1
6
*
8140/3-C25.9
ICD-O-3
Adenocarcinoma, NOS, of pancreas, NOS
+∞
6.1
6
*
8070/3-C44.4
ICD-O-3
Squamous cell carcinoma, NOS, of skin of scalp and neck
+∞
6.1
6
*
C43.62
ICD-10 Finland
Malignant melanoma of upper extremity including shoulder: 'superficial spreading' type
+∞
6.1
6
*
8090/3-C44.0
ICD-O-3
Basal cell carcinoma, NOS, of skin of lip, NOS
+∞
6.1
6
*
8140/2-C34.3
ICD-O-3
Adenocarcinoma in situ, NOS, of lower lobe, lung
+∞
6.1
6
*
8090/3-C44.7
ICD-O-3
Basal cell carcinoma, NOS, of skin of lower limb and hip
+∞
6.1
6
*
L04AX04
ATC
lenalidomide; oral
+∞
6.1
6
*
C43.6
ICD-10 Finland
Malignant neoplasm: Malignant melanoma of upper limb, including shoulder
+∞
6.1
6
*
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
+∞
6.1
6
*
1888X
ICD-9 Finland
Malignant neoplasm of bladder, Other specified sites of bladder
+∞
6.1
6
*
8070/3-C02.1
ICD-O-3
Squamous cell carcinoma, NOS, of border of tongue
+∞
6.1
6
*
8480/3-C18.2
ICD-O-3
Mucinous adenocarcinoma of ascending colon
+∞
6.1
6
*
C43.11
ICD-10 Finland
Malignant melanoma of the eyelids including corner of the eye originating in lentigo maligna
+∞
6.1
6
*
E24.3
ICD-10 Finland
Ectopic ACTH syndrome
+∞
6.1
6
*
C18.10
ICD-10 Finland
Malignant tumor of the appendix without histology
+∞
6.1
6
*
C84.0
ICD-10 Finland
Mycosis fungoides
+∞
6.1
6
*
C44.02
ICD-10 Finland
Spinocellular carcinoma of the lip skin
+∞
6.1
6
*
C21.1
ICD-10 Finland
Malignant neoplasm: Anal canal
+∞
6.1
6
*
C43.53
ICD-10 Finland
Malignant melanoma of the torso nodular
+∞
6.1
6
*
8070/3-C80.9
ICD-O-3
Squamous cell carcinoma, NOS, of unknown primary site
+∞
6.1
6
*
PJD63
NOMESCO Finland
Laparoscopic dissection of aortic lymph nodes
+∞
6.1
6
*
C54.10
ICD-10 Finland
Malignant tumor of endometrium without histology
+∞
6.1
6
*
1628C
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Other parts of bronchus or lung[NEOPL MAL PULMONIS LOCO MULTIPLICI,ADENOCARCINOMA]
+∞
6.1
6
*
1XA01
NOMESCO Finland
NA
+∞
6.1
6
*
C09.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of tonsil
+∞
6.1
6
*
1501
Kela drug reimbursment
Palbociclib
+∞
6.1
6
*
394
Kela drug reimbursment
Palbociclib
+∞
6.1
6
*
8551/3-C34.9
ICD-O-3
Acinar cell cystadenocarcinoma of lung, NOS
+∞
6.1
6
*
8010/3-C34.2
ICD-O-3
Carcinoma, NOS, of middle lobe, lung
+∞
6.1
6
*
C50.2
ICD-10 Finland
Malignant neoplasm: Upper-inner quadrant of breast
+∞
6.1
6
*
1622X
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Main bronchus[NEOPL MAL BRONCH PRINCIP,EI HIST/SYTOL DG]
+∞
6.1
6
*
K10.26
ICD-10 Finland
Periostitis of jaw (acute)(chronic)(suppurative)
+∞
6.1
6
*
NE049
NOMESCO Finland
Radiotherapy of methastasis in pelvis, sacrum or coggyx
+∞
6.1
6
*
GAE23
NOMESCO Finland
Resection of chest wall and prosthetic repair
+∞
6.1
6
*
NK6SN
NOMESCO Finland
Bone SPECT
+∞
6.1
6
*
GDA00
NOMESCO Finland
Incision and dranage of lung
+∞
6.1
6
*
C76.0
ICD-10 Finland
Malignant neoplasm of other and ill-defined sites: Head, face and neck
+∞
6.1
6
*
C02.0
ICD-10 Finland
Malignant neoplasm: Dorsal surface of tongue
+∞
6.1
6
*
C50.12
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,lobular tumor
+∞
6.1
6
*
C54.9
ICD-10 Finland
Malignant neoplasm: Corpus uteri, unspecified
+∞
6.1
6
*
C50.59
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, other or undeterminated histology
+∞
6.1
6
*
YN1AD
NOMESCO Finland
CT examination of extremities for dose design of radiotherapy
+∞
6.1
6
*
GBA22
NOMESCO Finland
Endoscopic excision of lesion of trachea
+∞
6.1
6
*
3026
Kela drug reimbursment
Lorlatinib
+∞
6.1
6
*
C18.29
ICD-10 Finland
Malignant tumor of the ascending colon or other unspecified histology
+∞
6.1
6
*
JFF23
NOMESCO Finland
Transversostomy
4.5
6.1
20
42
SPAT1216
SPAT
Assessment of functional ability
0.8
6.1
540
6173
N07BB01
ATC
disulfiram; oral
1.6
6.0
133
765
M10.9
ICD-10 Finland
Gout, unspecified
0.7
6.0
203
2646
JG1BG
NOMESCO Finland
MRI of rectum
16.8
6.0
9
5
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
1.8
6.0
92
474
4040
NOMESCO Finland
NA
10.3
6.0
11
10
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
1478
5021
3.28
311.57
4.4
2.5
u/l
243.1
242.1
0.09
1442
4609
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
1041
941
12.17
307.65
1.4
1.5
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
1707
2653
7.80
307.65
3.7
1.4
ug/l
58.2
8.6
3.84
1561
1998
(40768806) Pleura Pathology biopsy report
482
464
10.47
307.65
1.5
1.5
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
1083
1671
7.10
307.65
2.3
2.9
—
—
—
0
0
(4035726)
2217
1262
24.28
307.65
1.5
1.2
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
1093
481
25.41
307.65
1.2
1.1
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
434
495
8.77
307.65
1.4
1.5
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
462
356
13.06
307.65
1.6
1.4
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
452
528
8.58
307.65
1.4
1.5
e6/l
65496.4
70833.2
0.08
279
314
(3023199) Leukocytes [#/volume] in Pleural fluid
483
591
8.22
307.65
1.4
1.5
e6/l
2501.3
3000.4
0.28
354
437
(3042631) Mycobacterium sp identified in Specimen
538
686
7.95
307.65
1.9
3.0
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
1977
6916
3.41
307.65
4.4
2.4
mmol/l
0.8
0.8
38.53
1919
6277
(3003434) Protein [Mass/volume] in Pleural fluid
539
666
8.21
307.65
1.4
1.5
g/l
39.0
28.8
48.21
506
578
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
592
581
10.44
307.65
1.3
1.2
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
920
286
35.00
307.65
1.8
1.3
ug/l
17.9
21.1
0.54
913
277
(40768804) Tissue Pathology biopsy report
2809
13608
2.63
305.31
2.8
1.7
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
295
0
+∞
302.91
1.1
0.0
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
390
431
8.99
299.63
1.3
1.3
u/l
634.5
296.5
3.44
381
398
(3002256) Pathology report gross observation
1119
3378
3.55
282.62
1.4
1.1
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
1128
3444
3.51
279.79
5.7
1.8
nmol/l
425.8
367.2
14.30
1089
3070
(3036782) Glucose [Moles/volume] in Pleural fluid
367
429
8.47
269.47
1.3
1.4
mmol/l
5.8
6.7
3.99
346
390
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
326
328
9.80
268.46
1.2
1.3
u/l
11.5
11.7
0.08
316
292
(3045788) Cell count panel - Pleural fluid
364
451
7.99
254.66
1.4
1.6
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
2811
14792
2.37
241.14
7.0
5.2
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
3378
43993
0.44
226.41
3.9
4.9
mmol/l
1.4
1.4
3.31
2892
39672
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
3434
44405
0.44
224.68
3.9
4.9
mmol/l
4.5
4.4
2.14
2980
40394
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
3588
45619
0.44
223.97
4.4
5.6
mmol/l
2.6
2.6
3.46
3070
41290
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
251
230
10.65
220.48
1.2
1.2
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
3875
23936
2.25
219.77
15.5
6.0
e9/l
4.9
4.5
18.33
3444
20316
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
3690
22502
2.22
213.77
11.2
3.7
umol/l
9.7
12.5
29.13
3619
20965
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
3351
43342
0.46
208.71
5.8
6.8
mmol/mol
41.2
41.2
0.15
2933
39430
(3022096) Basophils/100 leukocytes in Blood
3321
19607
2.19
206.13
7.3
5.5
%
0.6
0.7
5.48
3244
17901
(3023368) Bacteria identified in Blood by Culture
2583
13941
2.22
199.15
4.9
3.9
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
3291
42583
0.46
198.48
3.6
4.4
mmol/l
1.3
1.3
5.10
2789
38039
(3019069) Monocytes/100 leukocytes in Blood
3367
20255
2.14
195.77
7.5
5.7
%
9.1
8.9
1.70
3290
18538
(3006504) Eosinophils/100 leukocytes in Blood
3351
20167
2.14
194.07
7.4
5.4
%
2.5
3.0
34.80
3276
18385
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
270
327
8.07
192.09
1.3
1.4
u/l
10.7
13.7
9.37
259
311
(3002030) Lymphocytes/100 leukocytes in Blood
3384
20635
2.11
186.90
7.5
5.6
%
22.4
26.2
75.50
3299
18761
(3018418) pH of Serum or Plasma
2517
13837
2.15
181.21
5.5
3.3
ph
7.4
7.4
1.64
456
2484
(3033658) Prothrombin time (PT) actual/Normal
2077
10674
2.21
176.54
5.5
3.5
%
92.4
83.0
58.45
2052
10391
(3001604) Monocytes [#/volume] in Blood
3458
21655
2.05
172.90
7.2
5.1
e9/l
0.7
0.6
40.88
2989
18302
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
809
2680
3.10
171.12
7.1
7.0
mmol/l
25.8
24.7
15.12
803
2641
(3018010) Neutrophils/100 leukocytes in Blood
3303
20405
2.04
170.78
7.3
5.4
%
62.1
58.5
51.07
3223
18670
(3006315) Basophils [#/volume] in Blood
3468
21822
2.03
170.11
7.2
5.2
e9/l
0.0
0.0
3.25
3001
18476
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
124
47
25.31
169.88
2.7
1.0
u/ml
38.6
16.1
2.36
118
40
(3035880) pH of Pleural fluid
230
268
8.34
168.76
1.2
1.3
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
3349
20861
2.03
168.40
7.4
11.6
inr
1.2
1.4
21.95
710
5687
(3018677) aPTT in Platelet poor plasma by Coagulation assay
1629
7723
2.31
166.93
2.1
1.8
s
29.9
30.2
1.76
1603
7478
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
776
2568
3.09
164.13
8.5
8.4
mmol/l
25.0
24.4
8.34
755
2309
(3019198) Lymphocytes [#/volume] in Blood
3484
22220
2.00
161.41
7.3
5.2
e9/l
1.7
1.8
1.20
3055
19121
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
3689
44854
0.50
160.95
5.1
5.2
mmol/l
6.2
6.1
0.78
3231
39975
(3013115) Eosinophils [#/volume] in Blood
3516
22530
1.99
160.29
7.5
5.3
e9/l
0.2
0.2
4.56
3070
19343
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
3415
21806
1.97
155.59
8.2
5.3
mmol/l
1.2
1.2
6.50
3275
19157
(4010399)
938
3565
2.72
153.42
1.4
1.4
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
316
588
5.27
148.37
1.3
1.3
u/l
14.4
9.7
4.98
260
466
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
1714
8673
2.16
147.16
5.6
2.2
mmol/l
2.5
2.5
72.69
1585
7356
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
3630
24080
1.92
143.04
9.4
5.7
mmol/l
1.2
1.2
1.78
3136
19999
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
1888
10012
2.08
142.68
2.6
2.2
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
2513
14776
1.97
141.96
5.7
2.1
mmol/l
2.4
2.3
13.93
2338
12104
(3044640) Blood type and Crossmatch panel - Blood
2294
13133
1.98
139.47
2.7
2.2
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
3119
19955
1.89
134.37
6.2
3.8
g/l
32.9
35.0
63.07
2978
18083
(3003396) Base excess in Arterial blood by calculation
1277
5960
2.26
132.36
7.6
6.6
mmol/l
1.5
1.2
2.08
1105
4566
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
1278
5993
2.25
130.81
7.6
6.5
kpa
5.4
5.0
24.55
1224
5690
(3000963) Hemoglobin [Mass/volume] in Blood
4324
49095
0.52
130.42
43.1
21.7
g/l
126.2
135.3
262.24
4251
47970
(3010813) Leukocytes [#/volume] in Blood
4325
49099
0.52
130.28
42.8
21.6
e9/l
8.1
6.9
65.41
4175
47079
(3027801) Oxygen [Partial pressure] in Arterial blood
1276
5989
2.25
130.26
7.6
6.5
kpa
11.5
11.3
0.52
1220
5673
(3026361) Erythrocytes [#/volume] in Blood
4324
49090
0.52
130.23
42.8
21.6
e12/l
4.3
4.5
125.92
4174
47059
(40758558) Short blood count panel - Blood
1855
10050
2.02
130.22
11.4
4.5
—
—
—
0
0
(3035941) MCH [Entitic mass]
4324
49085
0.52
130.05
42.6
21.5
pg
30.1
30.5
37.17
4243
47956
(3024731) MCV [Entitic volume]
4324
49085
0.52
130.05
42.7
21.5
fl
91.6
91.8
1.51
4244
47958
(3007461) Platelets [#/volume] in Blood
4324
49073
0.52
129.62
42.9
21.6
e9/l
272.1
237.9
138.14
4197
47283
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
703
2543
2.79
125.22
9.5
9.4
—
—
—
0
0
(3023383) Lactate [Moles/volume] in Pleural fluid
139
125
10.68
123.40
1.2
1.3
mmol/l
3.6
3.3
0.35
132
112
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
261
511
4.97
115.45
3.0
3.8
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
2206
13106
1.88
115.16
4.5
2.6
u/l
31.0
35.4
1.40
2142
12238
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
158
187
8.13
114.32
1.3
1.3
u/l
26.5
35.8
1.97
153
128
(3014111) Lactate [Moles/volume] in Serum or Plasma
979
4361
2.31
111.82
7.3
6.1
mmol/l
1.2
1.4
10.19
942
4159
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
130
127
9.82
108.93
1.2
1.2
ug/l
680.7
67.7
3.61
110
49
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
95
57
15.92
106.87
1.0
1.1
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
1297
6574
2.07
106.56
1.9
2.0
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
1115
5406
2.13
102.69
8.2
6.8
%
95.1
94.8
0.88
1085
5198
(3002173) Hemoglobin [Mass/volume] in Arterial blood
1016
4794
2.18
100.10
8.7
7.3
g/l
120.8
122.3
1.81
989
4610
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
1541
8470
1.93
99.71
2.0
1.8
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
4250
47506
0.57
97.69
19.8
9.5
u/l
24.1
25.1
3.47
4179
45069
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
3516
41283
0.58
97.09
5.9
4.6
mu/l
1.9
2.1
3.42
3135
36763
(3023103) Potassium [Moles/volume] in Serum or Plasma
4314
47963
0.57
95.78
32.7
18.2
mmol/l
4.0
4.0
0.79
4215
46428
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
141
180
7.52
95.72
1.3
1.4
%
65.1
66.2
0.13
124
147
(3001893) Eosinophils/100 leukocytes in Pleural fluid
131
155
8.10
94.78
1.3
1.4
%
4.8
2.2
1.77
120
128
(3000991) Gas panel - Venous blood
887
4047
2.23
94.64
8.4
7.5
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
491
1697
2.86
94.43
2.3
2.9
u/ml
0.3
0.3
1.14
266
987
(3019550) Sodium [Moles/volume] in Serum or Plasma
4315
47875
0.57
92.96
32.6
18.1
mmol/l
138.4
139.8
151.40
4226
46419
(3023419) Bacteria identified in Sputum by Culture
282
697
3.94
92.68
1.8
2.4
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
1192
6177
2.00
90.62
7.8
6.2
mmol/l
104.0
104.4
1.96
1165
5999
(40768795) Lymph node Pathology biopsy report
99
89
10.63
87.86
1.2
1.1
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
328
938
3.41
86.91
2.7
1.8
u/ml
730.6
90.9
1.50
279
754
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
163
274
5.72
85.21
1.6
1.6
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
319
935
3.33
81.25
1.5
1.4
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
328
979
3.27
81.13
1.5
1.4
—
—
—
0
0
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
104
112
8.87
81.05
1.3
1.4
%
19.2
27.5
1.55
93
91
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
534
2105
2.51
78.86
2.0
1.8
ug/l
1.9
1.8
0.05
486
1806
(3000919) Neutrophils/100 leukocytes in Pleural fluid
113
142
7.61
77.75
1.3
1.4
%
16.2
23.4
1.68
108
125
(40761511) CBC panel - Blood by Automated count
4137
45822
0.61
77.56
25.7
14.6
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
691
12415
0.47
76.71
1.6
1.7
mmol/l
1.4
1.3
1.58
585
10152
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
258
689
3.63
75.80
1.5
1.4
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
195
435
4.32
73.43
1.3
1.3
iu/l
31.3
33.8
0.40
152
374
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
1091
5893
1.89
71.80
2.0
1.7
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
1090
5900
1.89
71.22
2.0
1.7
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
1692
22866
0.59
70.68
4.5
4.1
ug/l
2.4
2.7
0.50
1440
20254
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
2763
19519
1.57
65.85
4.2
3.7
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
1278
18323
0.58
65.75
4.0
4.0
%
20.5
24.4
17.96
625
9414
(3020682) Albumin/Creatinine [Ratio] in Urine
1226
17769
0.57
65.68
3.8
4.0
mg/mmol
11.3
9.3
0.75
779
11370
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
260
772
3.26
64.76
1.6
1.3
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
1154
16901
0.57
63.79
2.9
3.2
mmol/l
7.2
7.4
0.73
904
13957
(3012516) Albumin [Mass/volume] in Urine
1141
16716
0.57
62.94
3.0
3.2
mg/l
468.0
272.6
0.74
751
10774
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
729
3663
1.98
58.71
2.8
2.1
u/l
33.1
37.9
1.23
643
3066
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
217
623
3.36
57.04
1.6
1.3
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
229
690
3.20
55.67
1.5
1.3
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
355
1357
2.55
55.57
1.5
1.7
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
3669
28206
1.50
55.30
7.5
4.5
mmol/l
6.8
6.9
5.69
3571
26354
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
209
598
3.37
55.23
1.5
1.3
—
—
—
0
0
(44786800) Granulocytes/100 leukocytes in Body fluid
58
50
11.02
52.88
1.3
1.2
%
18.7
20.4
0.13
52
32
(3004809) Band form neutrophils/100 leukocytes in Blood
204
591
3.32
52.86
2.2
2.9
%
1.5
1.4
0.08
176
442
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
3833
42002
0.67
52.08
29.5
13.8
ml/min/173m2
77.3
72.9
36.91
3457
33799
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
204
598
3.28
51.87
1.6
1.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
838
12807
0.56
51.81
3.1
3.4
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
1736
22220
0.64
51.56
1.9
2.1
pmol/l
89.5
92.5
1.99
921
11552
(3021589) Normoblasts [#/volume] in Blood
2605
19188
1.46
45.39
14.4
9.0
e9/l
0.0
0.0
0.20
2038
15604
(3019060) Gas panel - Arterial blood
692
3709
1.85
45.29
4.5
4.6
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
165
461
3.43
45.28
1.6
1.5
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
240
842
2.75
44.53
1.4
1.6
iu/l
3.1
4.3
1.42
41
249
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
219
732
2.88
44.48
3.6
3.4
%
61.9
59.4
1.89
219
732
(3020630) Protein [Mass/volume] in Serum or Plasma
782
4373
1.78
44.44
1.8
1.6
g/l
65.0
66.7
6.80
725
3844
(3003338) MCHC [Mass/volume]
3210
35901
0.70
44.10
39.4
19.6
g/l
328.1
332.0
106.37
3165
35490
(3000492) Spirometry study
668
3574
1.85
43.91
1.6
1.5
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
607
3151
1.90
43.85
1.8
1.7
—
—
—
0
0
(3034459) Mononuclear cells/100 leukocytes in Pleural fluid
52
52
9.49
42.81
1.3
1.4
%
81.9
69.8
1.44
47
39
(3017181) Myelocytes/100 leukocytes in Blood
666
3597
1.83
42.41
3.1
3.6
%
1.3
0.8
3.33
328
802
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
2953
33371
0.70
41.91
5.1
3.7
pmol/l
15.3
15.0
5.04
2681
29494
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
143
386
3.55
41.38
1.3
1.3
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
136
360
3.61
40.52
1.3
1.3
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
252
970
2.50
38.81
2.6
1.5
u/ml
69.0
29.3
1.86
242
918
(3008757) Leukocyte morphology finding [Identifier] in Blood
151
442
3.27
38.53
2.6
3.0
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
106
247
4.09
37.79
1.7
1.4
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
106
249
4.06
37.39
1.7
1.4
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
901
12594
0.62
36.78
3.0
2.9
ug/l
0.8
0.8
0.60
625
9029
(1616796) Gas panel - Central venous blood
276
1140
2.34
36.41
3.9
3.7
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
625
3461
1.77
36.39
3.1
3.6
%
0.2
0.1
1.72
304
745
(3041918) Cholesterol [Moles/volume] in Pleural fluid
59
84
6.67
36.39
1.2
1.2
mmol/l
2.0
1.4
2.72
53
46
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
117
302
3.70
36.20
1.7
1.3
—
—
—
0
0
(3012501) Base excess in Blood by calculation
274
1137
2.33
35.76
4.5
4.3
mmol/l
3.0
2.6
1.57
217
759
(3013290) Carbon dioxide [Partial pressure] in Blood
274
1139
2.32
35.61
4.5
4.3
kpa
5.1
5.0
1.18
269
1101
(3027315) Oxygen [Partial pressure] in Blood
275
1147
2.31
35.47
4.5
4.3
kpa
8.1
8.3
1.31
270
1108
(3002582) Erythrocytes [#/volume] in Urine
1998
14503
1.43
35.36
3.2
3.1
e6/l
79.4
115.5
0.81
1547
11136
(3030467) Casts [#/volume] in Urine by Automated count
1843
13205
1.44
34.96
3.2
3.0
e6/l
0.6
0.5
1.49
1395
9921
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
55
76
6.87
34.86
1.4
1.4
%
11.0
6.1
0.74
37
34
(36304419) Bacteria [Presence] in Urine
1763
12546
1.44
34.65
3.2
3.0
—
—
—
0
0
(3026782) Osmolality of Urine
1376
9341
1.49
34.51
2.7
2.7
mosm/kgh2o
537.4
556.6
2.58
1206
7794
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
124
344
3.44
34.47
1.3
1.2
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
124
344
3.44
34.47
1.3
1.2
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
124
344
3.44
34.47
1.3
1.2
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
2006
14624
1.42
34.46
4.7
2.3
u/l
58.8
60.4
0.56
1911
13325
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
1485
18511
0.69
34.10
2.0
2.2
nmol/l
76.2
79.0
2.98
1298
15927
(3002179) Metamyelocytes/100 leukocytes in Blood
591
3289
1.76
33.74
3.1
3.5
%
0.7
0.5
0.83
245
595
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
550
2997
1.79
33.74
1.6
1.5
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
284
1230
2.23
33.50
2.0
2.2
g/l
121.3
130.1
4.53
152
923
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
1140
7484
1.53
33.47
2.9
2.8
e6/l
2.3
2.1
0.34
612
4171
(40768793) Breast Pathology biopsy report
88
197
4.25
33.11
1.2
1.2
—
—
—
0
0
(3010421) pH of Blood
297
1322
2.17
32.74
4.6
4.2
ph
7.4
7.4
1.30
269
1101
(3009343) pH of Capillary blood
603
3415
1.73
32.33
4.1
3.6
ph
7.4
7.4
0.26
80
423
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
125
364
3.28
32.22
1.6
1.4
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
587
3310
1.74
31.95
4.0
3.5
mmol/l
2.6
1.9
3.99
484
2394
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
1478
10317
1.45
31.76
4.8
4.2
ng/l
304.5
568.6
2.37
1302
8831
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
606
3466
1.71
31.32
4.1
3.6
kpa
5.3
5.1
2.53
574
3181
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
385
1918
1.95
31.25
1.9
2.2
ug/l
365.2
659.2
1.01
348
1806
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
579
3275
1.73
31.14
1.5
1.6
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
597
3416
1.71
30.79
2.0
1.9
g/l
0.2
0.2
1.17
553
3068
(3019150) Specific gravity of Urine by Refractometry
754
10579
0.63
30.38
3.9
4.2
kg/l
1.0
1.0
0.02
115
1611
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
259
1130
2.21
30.01
1.2
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
259
1131
2.20
29.95
1.2
1.3
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
869
11771
0.65
29.65
1.6
1.7
pmol/l
15616504.9
29300927.0
0.39
698
9464
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
4175
34732
1.35
29.64
15.7
5.4
u/l
86.6
77.3
30.85
4100
31858
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
1411
17380
0.70
29.09
3.9
4.1
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
161
576
2.67
28.84
4.2
5.0
iu/ml
347.1
741.5
0.54
22
81
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
4308
44732
0.74
28.25
31.8
14.8
mg/l
37.8
26.0
83.27
4124
35657
(44806118)
134
445
2.88
27.64
1.5
1.4
—
—
—
0
0
(44790049)
134
445
2.88
27.64
1.5
1.4
—
—
—
0
0
(44790048)
134
445
2.88
27.64
1.5
1.4
—
—
—
0
0
(44790047)
134
445
2.88
27.64
1.5
1.4
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
90
241
3.55
26.48
4.4
3.9
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
56
104
5.11
26.42
1.1
1.2
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
243
1092
2.14
26.17
2.6
2.5
%
14.8
16.3
4.89
118
593
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
726
4545
1.57
25.96
2.5
2.2
umol/l
8.7
8.5
0.05
638
3891
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
33
36
8.68
25.45
3.7
1.2
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
82
212
3.68
25.42
1.7
1.8
e9/l
0.9
1.0
0.81
55
125
(3022313) Gas panel - Capillary blood
444
2467
1.75
25.34
4.4
3.7
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
3616
38263
0.76
25.27
32.3
16.3
%
37.8
38.9
11.19
2343
23285
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
61
129
4.49
24.73
1.2
1.3
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
64
141
4.31
24.65
1.3
1.4
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
61
130
4.45
24.50
1.2
1.2
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
61
130
4.45
24.50
1.2
1.2
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
550
3270
1.64
24.35
3.3
3.7
%
0.0
0.3
0.98
266
647
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
97
289
3.19
24.18
2.8
4.2
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
44
72
5.79
23.77
1.3
2.1
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
72
180
3.80
23.44
1.2
1.2
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
72
180
3.80
23.44
1.2
1.2
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
72
180
3.80
23.44
1.2
1.2
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
72
180
3.80
23.44
1.2
1.2
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
62
142
4.14
22.74
2.2
2.6
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
1986
22529
0.76
22.14
3.5
3.8
estimate
0.0
0.0
0.50
447
3854
(3028626) Oxygen [Partial pressure] in Capillary blood
254
1235
1.98
22.13
3.0
2.8
kpa
7.7
7.8
0.16
240
1146
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
96
300
3.04
22.13
1.1
1.2
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
2016
22787
0.76
21.75
3.6
3.8
estimate
0.0
0.0
1.60
430
3759
(3021901) Oxygen saturation in Capillary blood
228
1075
2.03
21.66
2.9
2.7
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
19
11
16.32
21.46
1.1
1.2
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
118
420
2.68
21.45
1.2
1.1
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
113
395
2.73
21.27
2.2
2.7
%
56.4
60.0
0.80
89
256
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
468
6796
0.62
21.16
11.7
7.6
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
1992
22486
0.76
21.05
4.8
5.0
estimate
0.0
0.0
0.50
453
3911
(3018095) Leukocytes [#/volume] in Urine
2131
16668
1.30
20.59
3.7
3.5
e6/l
77.9
119.2
1.66
1582
11942
(3052851) Hemolysis interference index of Serum or Plasma
271
1381
1.89
20.56
3.9
3.6
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
700
4564
1.50
20.54
4.4
6.5
mmol/l
8.6
11.7
27.37
668
4268
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
35
53
6.25
20.42
5.8
1.3
u/l
29.4
49.2
0.83
22
18
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
202
938
2.06
20.03
1.9
2.2
%
220.9
198.3
3.36
191
886
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
1135
8131
1.38
19.87
2.9
2.6
e6/l
1.0
1.2
0.80
607
4779
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
140
563
2.37
19.75
2.7
1.8
u/ml
106.1
549.6
0.87
127
512
(1617658) Protocol used for examination of sentinel lymph nodes
24
5
45.37
19.58
1.0
1.0
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
375
2135
1.69
19.57
1.9
1.8
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
1044
12782
0.73
19.02
1.5
1.6
nmol/l
20.1
20.0
0.10
912
10762
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
211
1015
1.99
19.00
1.9
2.2
g/l
4.1
3.6
3.92
203
952
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
59
150
3.73
18.82
1.5
1.9
—
—
—
0
0
(40768441) Liver Pathology biopsy report
58
146
3.77
18.77
1.2
1.3
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
60
155
3.67
18.71
1.6
1.8
%
10.4
16.8
2.55
16
65
(21494814) CD8 cells/100 lymphocytes in Specimen
42
83
4.79
18.53
1.5
2.1
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
1038
12652
0.73
18.25
4.0
4.2
estimate
0.0
0.0
0.33
393
3733
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
195
929
2.01
18.06
1.4
1.6
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
29
42
6.53
17.65
1.1
1.1
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
272
1463
1.78
17.37
3.3
3.0
mmol/l
25.7
24.8
2.67
242
1298
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
604
3965
1.48
17.04
5.5
3.1
mmol/l
1.2
1.2
2.42
570
3338
(3000494) Fungus identified in Specimen by Culture
745
5091
1.43
17.00
1.4
1.4
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
625
8195
0.69
16.86
1.2
1.2
u/ml
2.4
1.8
0.41
115
2104
(3003458) Phosphate [Moles/volume] in Serum or Plasma
879
6191
1.39
16.84
4.4
5.3
mmol/l
1.0
1.0
2.11
830
5623
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
464
6438
0.66
16.76
3.6
5.1
%
33.0
33.2
0.14
298
4213
(3042552) Rheumatoid factor [Units/volume] in Pleural fluid
26
36
6.83
16.48
1.0
1.1
iu/ml
41.1
16.8
—
10
15
(3026493) Urate [Moles/volume] in Serum or Plasma
1093
13054
0.75
16.47
2.7
2.6
umol/l
4104.9
6308.1
1.04
901
10953
(46235355) HIV 1 and 2 tests - Meaningful Use set
562
3672
1.48
16.21
1.3
1.5
—
—
—
0
0
(3014891) Appearance of Pleural fluid
41
91
4.27
15.74
1.5
1.6
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
386
2345
1.58
15.57
2.6
4.0
mmol/l
24.6
24.1
1.90
367
2073
(3019309) Folate [Moles/volume] in Red Blood Cells
951
11501
0.74
15.49
1.8
1.8
nmol/l
1069.7
1145.2
1.69
715
8570
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
55
153
3.41
15.42
1.9
1.6
e6/l
498.5
701.3
1.21
22
69
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
45
109
3.91
15.41
1.2
2.2
u/ml
2357.5
96744.7
—
8
18
(3002385) Erythrocyte distribution width [Ratio]
3414
35429
0.81
15.20
37.6
17.6
%
14.5
13.8
124.32
3369
34433
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
333
1972
1.62
14.94
1.8
1.7
—
—
—
0
0
(3044889) 12 lead EKG panel
3163
32987
0.82
14.36
4.9
4.3
—
—
—
0
0
(3036489) Thrombin time
254
1419
1.71
14.26
1.7
1.8
s
21.7
21.5
0.15
235
1254
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
343
2078
1.59
14.01
4.8
4.0
mmol/l
25.6
24.8
4.91
328
1890
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
292
4314
0.62
13.98
1.6
1.6
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
71
246
2.74
13.74
1.9
2.1
—
—
—
0
0
(40758047) Lysozyme [Mass/volume] in Pleural fluid
27
47
5.43
13.74
1.2
1.1
mg/l
6.6
8.7
0.61
27
42
(3051611) Lipemic interference index of Serum or Plasma
113
487
2.21
13.69
4.2
3.5
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
1317
10128
1.28
13.49
2.6
2.5
e6/l
6.0
4.4
3.88
1175
8744
(3021879) Hepatitis B virus core Ab [Presence] in Serum
302
1797
1.61
13.31
1.2
1.3
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
104
450
2.20
12.52
1.8
2.3
u/ml
307.1
668.0
—
7
28
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
1233
9486
1.28
12.48
1.6
1.7
mg/l
1.9
1.3
3.28
1036
7354
(3003181) Sodium [Moles/volume] in Urine
169
873
1.85
12.42
1.3
1.3
mmol/l
58.8
63.8
0.87
132
694
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
45
127
3.35
12.41
2.2
2.2
%
41.8
43.8
0.18
11
54
(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid
27
52
4.91
12.32
1.2
1.2
u/l
21.6
14.3
1.49
22
31
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
525
6667
0.72
11.45
1.2
1.2
u/ml
31.0
15.1
0.79
148
2386
(40760892) CBC W Ordered Manual Differential panel - Blood
1129
8682
1.27
11.37
5.6
4.1
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
569
7107
0.73
11.15
1.2
1.3
iu/ml
44.3
40.0
0.28
168
2187
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
25
50
4.73
10.95
1.1
1.2
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
511
3527
1.40
10.91
7.8
6.8
mmol/l
25.5
24.5
8.61
483
3290
(4281824)
58
208
2.64
10.60
1.2
1.2
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
41
121
3.21
10.58
3.2
1.1
u/ml
81.2
91.2
0.06
12
37
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
269
3783
0.66
10.25
1.4
1.3
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
685
5037
1.31
9.67
3.2
3.6
mmol/l
2.4
1.9
3.09
572
4069
(4034850)
93
1691
0.51
9.59
12.1
11.2
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
176
996
1.68
9.55
1.2
1.2
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
684
5052
1.31
9.34
3.2
3.6
kpa
5.9
5.8
1.42
663
4885
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1650
17778
0.83
9.03
2.6
2.8
ug/l
228.3
146.5
13.55
1502
16021
(3028433) Virus identified in Specimen by Culture
41
134
2.89
8.96
1.1
1.1
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
65
1295
0.47
8.82
1.5
1.5
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
44
151
2.76
8.80
2.0
1.5
e6/l
439.4
416.3
0.15
37
131
(3039000) Anion gap in Blood
189
1117
1.61
8.69
7.6
6.6
mmol/l
10.4
11.4
4.11
167
1010
(3018572) Chloride [Moles/volume] in Blood
189
1117
1.61
8.69
7.6
6.6
mmol/l
103.8
105.0
2.34
167
1010
(3036603) Volume of Urine
65
272
2.26
8.61
1.2
1.4
ml
2127.7
1923.6
0.48
30
69
(3011397) Hemoglobin [Presence] in Urine by Test strip
989
11144
0.81
8.49
3.2
3.8
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
69
301
2.17
8.29
1.1
1.1
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
284
1860
1.46
8.17
3.0
1.8
—
—
—
0
0
(40761535) Cells panel - Urine sediment
344
4423
0.72
8.05
3.6
3.3
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
439
3108
1.35
8.04
1.3
1.5
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
422
2974
1.36
7.97
1.3
1.5
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
794
6116
1.25
7.72
2.2
2.0
%
1.8
1.7
0.72
712
5278
(3037467) Urinalysis macro (dipstick) panel - Urine
3133
31805
0.86
7.71
4.3
4.3
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
246
1586
1.48
7.69
7.2
5.9
mmol/l
1.1
1.3
4.52
218
1412
(3041096) Erythrocytes [Presence] in Urine by Automated
1024
11389
0.82
7.65
3.6
3.5
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
84
420
1.90
7.02
1.2
1.3
mosm/kgh2o
272.7
276.8
0.81
70
309
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
135
2020
0.62
6.92
1.7
1.9
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
110
1728
0.59
6.90
1.1
1.1
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
322
2226
1.38
6.89
1.4
1.5
u/ml
16.6
19.4
—
8
57
(3019977) pH of Arterial blood
69
325
2.01
6.86
2.4
2.2
ph
7.4
7.4
0.90
30
127
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
305
2095
1.39
6.79
3.9
2.9
pmol/l
4.3
4.4
1.49
283
1794
(3039443) Prostate specific Ag panel - Serum or Plasma
34
779
0.41
6.72
1.3
1.6
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
219
1430
1.46
6.48
1.3
1.2
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
201
2720
0.69
6.36
2.3
2.4
au/ml
20.5
24.0
0.20
11
89
(3003694) ABO and Rh group [Type] in Blood
1242
10183
1.18
6.36
1.3
1.3
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
178
2458
0.67
6.28
1.3
1.3
au/ml
39.3
53.5
—
10
105
(3044416) Complement C4 [Mass/volume] in Pleural fluid
14
28
4.72
6.16
1.1
1.1
g/l
0.1
0.1
0.14
14
18
(3007853) Bacteria identified in Skin by Aerobe culture
687
5340
1.24
6.14
1.6
1.8
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
51
224
2.15
6.13
1.2
1.2
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
51
224
2.15
6.13
1.2
1.2
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
69
341
1.92
6.03
1.2
1.1
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
149
2106
0.66
5.93
2.0
1.9
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
351
4290
0.76
5.88
1.9
2.1
ug/g
169.9
162.6
0.11
273
3298
(3008536) Aspergillus sp Ab [Presence] in Serum
21
60
3.31
5.81
1.2
1.4
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
98
1512
0.60
5.78
1.3
1.4
—
—
—
0
0
(3004451) EKG impression Narrative
59
281
1.99
5.75
1.4
1.3
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
23
72
3.02
5.51
2.1
1.5
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
226
2918
0.72
5.49
1.2
1.2
—
—
—
0
0
(3013512) EKG study
1456
15327
0.87
5.42
4.6
4.4
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
234
2991
0.73
5.34
1.1
1.2
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
61
304
1.90
5.25
1.2
1.2
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
62
311
1.89
5.24
1.2
1.2
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
168
1093
1.46
5.15
1.8
1.9
mg/l
11.6
11.7
0.08
159
998
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
106
1559
0.63
5.13
1.4
1.3
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
49
231
2.01
4.96
1.1
1.2
u/l
29.0
21.0
0.49
44
192
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
43
783
0.51
4.67
1.6
1.3
—
—
—
0
0
(4015189)
39
174
2.12
4.59
1.9
2.5
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
43
777
0.52
4.56
1.4
1.5
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
20
65
2.91
4.54
1.3
1.0
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
55
917
0.56
4.46
1.7
1.8
—
—
—
0
0
(4094501)
89
1315
0.63
4.45
1.1
1.1
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
79
449
1.67
4.44
2.7
2.9
—
—
—
0
0
(3008898) HLA-B27 [Presence]
55
908
0.57
4.32
1.0
1.1
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
16
47
3.21
4.29
1.3
1.0
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
2051
20873
0.89
4.28
2.6
2.2
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
829
6796
1.17
4.19
2.2
2.7
%
18.9
22.2
7.46
743
5646
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
28
567
0.46
4.19
1.4
1.5
—
—
—
0
0
(3046861) Legionella sp Ag [Presence] in Urine
11
25
4.15
4.18
1.2
1.1
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
158
1061
1.41
4.16
2.9
2.7
mg/l
1.4
1.8
8.66
149
923
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
244
1760
1.32
4.10
1.8
1.8
u/l
38.2
38.0
0.04
210
1473
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
279
2053
1.29
4.05
1.1
1.2
iu/ml
122.4
122.5
0.00
46
736
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
63
985
0.60
4.04
1.8
1.6
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
75
432
1.64
4.04
1.1
1.2
u/l
61.4
56.7
0.27
62
274
(4146454)
38
681
0.52
3.98
2.5
2.7
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
635
6965
0.84
3.95
1.4
1.3
g/l
2.7
2.7
0.23
343
3830
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
35
160
2.07
3.92
1.2
1.1
—
—
—
0
0
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
7
7
9.43
3.86
2.0
1.0
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
9
14
6.06
3.80
1.1
1.4
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
49
256
1.81
3.75
1.5
1.5
u/l
4.2
7.1
0.73
31
104
(3043409) Potassium [Moles/volume] in Arterial blood
233
1698
1.30
3.67
4.7
4.3
mmol/l
4.0
3.9
0.43
213
1586
(3007930) Methemoglobin/Hemoglobin.total in Blood
301
2269
1.26
3.64
6.1
4.8
%
0.9
0.9
0.66
278
2141
(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid
6
5
11.32
3.63
1.0
1.0
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
105
672
1.48
3.61
1.1
1.3
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
305
2306
1.26
3.60
6.0
4.7
%
1.9
1.6
2.72
281
2177
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
43
717
0.56
3.57
1.5
1.5
%
70.4
62.4
0.92
29
462
(3001964) Herpes simplex virus Ag [Presence] in Specimen
25
104
2.27
3.54
1.6
1.4
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2622
26126
0.91
3.40
4.8
3.0
u/l
67.4
51.2
7.57
2429
23500
(3022621) pH of Urine by Test strip
281
3281
0.80
3.36
2.6
3.0
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
80
1131
0.66
3.35
1.5
1.7
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
15
50
2.83
3.30
1.0
1.0
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
8
228
0.33
3.29
1.0
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
8
228
0.33
3.29
1.0
1.2
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
523
4216
1.18
3.28
3.0
3.1
kpa
4.5
4.4
0.16
505
4056
(3017446) Testosterone [Moles/volume] in Serum or Plasma
337
2606
1.23
3.27
1.8
2.2
nmol/l
9.4
14.7
24.58
277
2206
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
241
2851
0.79
3.24
2.7
2.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
85
535
1.50
3.21
1.2
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
85
536
1.50
3.19
1.2
1.3
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
611
5003
1.17
3.17
4.8
3.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
85
538
1.50
3.14
1.2
1.3
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
25
110
2.15
3.14
3.4
2.8
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
29
136
2.01
3.10
3.4
2.2
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
36
183
1.86
3.06
1.1
1.2
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
10
27
3.49
3.05
2.9
1.3
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
562
4596
1.17
2.98
2.1
2.1
e9/l
72.0
67.3
1.96
367
3528
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
82
525
1.48
2.89
1.1
1.3
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
11
33
3.14
2.88
1.4
1.2
—
—
—
0
0
(3023436) Glucagon [Mass/volume] in Serum or Plasma
7
12
5.50
2.88
1.1
1.5
ng/l
328.0
209.2
—
7
12
(3019225) pH of Specimen
609
5026
1.16
2.87
5.9
3.7
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
194
1433
1.28
2.84
2.2
1.5
g/l
0.0
0.0
0.00
174
1294
(3004789) Transferrin [Mass/volume] in Serum or Plasma
858
7254
1.13
2.83
2.1
2.6
g/l
2.2
2.3
3.30
809
6615
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
13
44
2.79
2.81
1.1
1.1
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
348
2747
1.20
2.80
2.1
2.2
g/l
10.2
10.9
2.90
319
2486
(44816559) Phosphatidylethanol [Mass/volume] in Blood
42
655
0.60
2.79
1.1
1.3
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
12
39
2.90
2.78
1.0
1.2
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
11
34
3.05
2.76
1.4
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
11
34
3.05
2.76
1.4
1.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
11
34
3.05
2.76
1.4
1.0
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
14
50
2.64
2.75
1.3
1.0
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
6
9
6.29
2.74
4.5
5.1
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
84
548
1.45
2.72
1.2
1.3
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
168
1227
1.30
2.70
1.5
1.6
iu/ml
60.9
5.2
0.45
48
288
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
196
1464
1.27
2.65
2.2
1.5
g/l
0.0
0.0
0.50
174
1300
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
69
953
0.68
2.65
2.1
1.4
nmol/l
1.1
0.8
0.75
56
769
(4024509)
31
515
0.57
2.64
1.5
1.6
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
51
301
1.60
2.62
2.4
1.9
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
85
562
1.43
2.58
1.2
1.3
—
—
—
0
0
(3011325) HIV 1+2 Ab [Presence] in Serum
6
10
5.66
2.57
1.0
1.0
—
—
—
0
0
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
6
10
5.66
2.57
1.0
1.0
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
12
41
2.76
2.56
1.2
1.0
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
83
548
1.43
2.54
1.2
1.3
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
11
36
2.88
2.52
2.2
1.6
e6/l
12193.3
140.9
—
6
23
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
9
24
3.54
2.51
1.0
1.0
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
137
986
1.32
2.48
1.9
2.4
umol/l
33.1
33.2
0.01
109
824
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
32
169
1.79
2.47
2.1
2.3
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
32
169
1.79
2.47
2.1
2.3
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
123
1522
0.76
2.44
2.2
2.3
ug/min
76.7
111.1
1.19
68
881
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
11
37
2.80
2.41
1.0
1.1
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
919
7885
1.11
2.37
2.1
2.6
umol/l
10.1
12.5
18.93
868
7180
(3006442) Creatine [Moles/volume] in Serum or Plasma
16
314
0.48
2.35
1.3
1.8
—
68.8
—
0
17
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
11
38
2.73
2.31
2.6
2.2
—
—
—
0
0
(3020891) Body temperature
279
2203
1.20
2.30
5.3
4.8
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
44
644
0.64
2.29
1.0
1.1
iu/ml
10.9
675.2
—
10
122
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
84
569
1.40
2.27
1.1
1.3
nmol/l
0.6
2.5
0.51
79
546
(3000475) Leukocytes [#/volume] in Synovial fluid
109
1356
0.75
2.27
1.6
1.5
e6/l
34165.6
13763.6
0.87
83
977
(3000034) Microalbumin [Mass/volume] in Urine
35
537
0.61
2.24
2.1
3.0
mg/l
15.9
35.6
2.24
26
395
(3025577) Chromium [Mass/volume] in Blood
26
430
0.57
2.23
1.8
2.0
ug/l
2.4
2.2
0.20
21
355
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
97
1222
0.74
2.21
1.4
1.5
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
84
573
1.39
2.19
1.1
1.3
nmol/l
0.1
0.4
—
6
44
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
85
1090
0.73
2.19
1.4
1.4
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
440
3627
1.15
2.17
3.8
4.1
—
—
—
0
0
(1002224) Polysomnography panel
91
1153
0.74
2.17
1.0
1.1
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
36
206
1.65
2.14
1.0
1.1
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
5
143
0.33
2.14
4.0
7.8
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
35
529
0.62
2.12
1.5
1.5
%
20.8
27.8
0.81
23
344
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
88
609
1.37
2.12
4.6
6.2
mg/l
11.7
12.3
0.56
83
547
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
31
171
1.71
2.11
1.4
1.5
umol/l
69.8
138.8
1.39
22
94
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
63
841
0.70
2.08
1.1
1.2
u/l
39.2
26.7
0.56
52
716
(3000330) Specific gravity of Urine by Test strip
249
2786
0.84
2.06
3.8
3.5
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
54
345
1.48
2.02
1.1
1.2
titre
191.8
138.4
0.19
11
56
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
7
19
3.47
2.02
1.0
1.0
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
5
136
0.35
2.01
3.8
5.9
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
71
479
1.40
2.00
1.1
1.4
u/ml
152.4
126.3
0.27
16
94
(3000012) Reticulocyte production index
16
295
0.51
2.00
1.4
1.5
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
81
561
1.37
1.96
1.1
1.4
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
91
1133
0.75
1.95
1.2
1.4
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
6
15
3.77
1.92
1.0
1.1
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
56
750
0.70
1.91
1.1
1.2
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
1959
17553
1.07
1.88
3.0
3.2
ng/l
1298.1
1800.5
10.03
1771
15170
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
23
373
0.58
1.88
1.1
1.1
u/ml
2.7
3.8
—
7
117
(3010144) Erythrocytes [#/volume] in Synovial fluid
37
531
0.65
1.82
1.5
1.3
e6/l
427624.9
209099.5
0.40
27
367
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
5
127
0.37
1.75
9.6
12.3
mmol/l
0.7
0.7
—
5
117
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
199
1568
1.20
1.75
2.2
1.5
g/l
0.2
0.0
0.49
177
1399
(3037556) Urate [Mass/volume] in Serum or Plasma
10
206
0.46
1.74
2.3
1.3
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
141
1076
1.24
1.71
1.9
3.0
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
34
205
1.57
1.70
1.5
1.4
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
43
589
0.69
1.70
2.0
1.5
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
46
298
1.46
1.66
2.1
1.6
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
112
836
1.27
1.65
1.2
1.4
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
35
495
0.66
1.64
1.2
1.2
nmol/l
290.1
324.2
0.49
24
383
(3028026) IgM [Mass/volume] in Serum or Plasma
270
2199
1.16
1.64
1.8
1.4
g/l
1.9
1.2
2.01
247
1966
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
5
123
0.38
1.62
1.6
1.4
ug/l
11.8
9.5
—
5
123
(3002619) Bacteria identified in Specimen by Culture
17
85
1.89
1.62
1.2
1.3
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
127
1476
0.81
1.62
1.7
1.6
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
1829
16430
1.07
1.61
2.4
2.2
u/l
143.9
243.0
10.03
1747
15278
(3035320) C reactive protein [Mass/volume] in Body fluid
47
312
1.42
1.52
2.2
2.5
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
43
281
1.44
1.51
1.1
1.1
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
35
220
1.50
1.49
1.1
1.0
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
16
81
1.86
1.49
1.1
1.1
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
44
583
0.71
1.48
1.1
1.0
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
10
42
2.25
1.47
1.0
2.0
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
140
1088
1.22
1.47
1.5
1.2
—
—
—
0
0
(4027681)
28
168
1.57
1.46
1.2
1.2
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
529
5470
0.90
1.46
2.2
2.5
ug/l
4.9
7.5
4.68
468
4681
(3022217) INR in Platelet poor plasma by Coagulation assay
806
8173
0.92
1.46
23.2
30.6
inr
1.4
1.5
1.64
115
1097
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
207
1669
1.17
1.46
2.1
1.5
g/l
36.7
37.4
1.02
181
1373
(3027653) Mycophenolate [Mass/volume] in Serum or Plasma
5
15
3.14
1.43
3.6
2.0
mg/l
2.3
1.8
—
5
9
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
32
444
0.68
1.40
1.4
2.1
u/field
2.1
1.6
0.18
12
169
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
6
128
0.44
1.40
1.0
1.1
miu/ml
1882.5
1719.7
—
6
128
(3024869) Neuronal Ab [Presence] in Serum
17
90
1.78
1.39
1.2
1.1
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
70
507
1.30
1.35
1.1
1.1
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
88
657
1.27
1.35
6.4
18.7
mmol/l
7.8
7.5
0.27
73
535
(3044927) Protein electrophoresis panel - Urine
51
647
0.74
1.34
1.2
1.2
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
20
113
1.67
1.33
2.4
2.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
87
650
1.26
1.33
1.3
1.3
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
297
2479
1.14
1.33
1.5
1.5
g/l
2.0
1.5
8.56
252
2098
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
70
509
1.30
1.32
1.2
1.2
u/ml
2.9
4.2
0.35
21
164
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
16
85
1.78
1.31
1.4
1.4
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
66
803
0.77
1.30
2.4
3.2
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
30
189
1.50
1.29
1.6
1.3
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
30
189
1.50
1.29
1.6
1.3
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
42
283
1.40
1.29
1.1
1.1
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
36
236
1.44
1.28
1.0
1.1
mg/l
51.0
41.4
0.57
31
199
(3013945) Hepatitis B virus e Ab [Presence] in Serum
5
17
2.77
1.27
1.0
1.1
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
1301
12867
0.94
1.19
2.2
2.3
mg/l
3.3
3.0
3.78
1116
10783
(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum
0
33
0.00
1.15
0.0
1.2
—
0.8
—
0
19
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
33
0.00
1.15
0.0
1.0
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
26
358
0.68
1.14
1.4
2.3
mmol/l
6.4
7.0
0.58
18
236
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
120
947
1.20
1.14
1.3
1.3
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
35
455
0.72
1.12
1.1
1.2
mmol/l
8.2
7.8
0.21
24
318
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
41
284
1.36
1.11
1.2
1.3
u/ml
0.4
1.1
0.78
24
149
(4211845)
18
265
0.64
1.10
3.6
3.1
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
18
105
1.62
1.09
1.2
1.1
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
3543
34087
0.96
1.07
5.3
4.2
mm/h
21.8
13.2
96.35
3371
30986
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
212
1763
1.14
1.06
2.2
1.5
g/l
1.3
0.5
1.47
178
1466
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
239
2004
1.13
1.05
2.1
1.4
g/l
10.5
10.5
0.09
200
1636
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
11
56
1.85
1.04
1.7
1.6
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
9
43
1.97
1.04
1.0
1.1
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
51
370
1.30
1.03
1.3
1.5
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
9
44
1.93
1.02
1.0
1.1
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
366
3772
0.91
1.01
1.7
1.7
%
1.8
1.6
2.62
296
3134
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
68
514
1.25
1.00
1.1
1.1
g/l
1.6
1.5
0.74
61
453
(3006462) Nitrate [Presence] in Urine
16
236
0.64
1.00
2.3
3.2
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
9
152
0.56
0.98
1.0
1.6
ug/l
5.6
9.2
—
9
130
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
117
1292
0.85
0.97
1.8
1.7
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
30
0.00
0.96
0.0
1.0
—
—
—
0
0
(4198724)
11
58
1.79
0.95
1.5
1.4
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
156
1283
1.15
0.94
2.4
1.5
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
20
125
1.51
0.94
1.6
1.5
—
—
—
0
0
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
6
25
2.26
0.94
1.2
1.1
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
25
164
1.44
0.94
1.8
1.8
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
38
472
0.76
0.94
1.0
1.1
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
8
39
1.93
0.89
1.0
1.3
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
93
1036
0.84
0.88
1.2
1.1
titre
561.7
1182.6
—
6
34
(3016038) Potassium [Moles/volume] in Urine
46
338
1.28
0.88
1.1
1.1
mmol/l
37.9
34.8
0.45
41
280
(3011648) Oxygen content in Venous blood
48
355
1.28
0.87
1.3
2.0
%
11.3
11.0
0.16
48
355
(3014051) Protein [Presence] in Urine by Test strip
101
1115
0.85
0.86
2.3
2.2
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
39
476
0.77
0.86
1.3
1.7
u/ml
23.8
26.1
—
9
115
(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]
14
204
0.65
0.86
2.8
5.8
%
71.4
71.5
—
9
171
(3005322) IgE [Units/volume] in Serum or Plasma
258
2208
1.11
0.84
1.2
1.3
u/ml
251.4
238.5
0.11
235
2031
(3006653) Thiamine [Moles/volume] in Blood
15
214
0.66
0.84
1.3
1.1
nmol/l
135.8
139.0
0.13
15
214
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
64
494
1.22
0.82
1.2
1.2
u/ml
3.5
4.8
0.79
28
224
(40759836) Histone Ab [Presence] in Serum by Immunoblot
38
275
1.30
0.82
1.1
1.1
—
—
—
0
0
(4212803)
8
44
1.71
0.81
1.1
1.0
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
38
276
1.30
0.81
1.1
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
38
276
1.30
0.81
1.1
1.1
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
0
23
0.00
0.79
0.0
1.1
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
79
626
1.19
0.79
1.2
1.6
g/l
0.8
0.9
0.25
54
478
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
0
24
0.00
0.79
0.0
1.3
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
11
62
1.67
0.78
1.8
1.5
umol/l
47.5
43.7
0.19
11
62
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
30
373
0.76
0.78
1.1
1.1
u/ml
0.6
1.4
1.07
11
140
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
7
116
0.57
0.78
1.0
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
38
278
1.29
0.77
1.1
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
38
278
1.29
0.77
1.1
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
38
279
1.29
0.76
1.1
1.1
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
53
406
1.23
0.75
1.2
1.4
g/l
3.0
3.0
0.03
31
288
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
11
163
0.64
0.74
1.0
1.2
—
9.9
—
0
15
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
8
125
0.60
0.73
1.0
1.2
%
—
35.3
—
0
12
(3013293) Extractable nuclear Ab [Presence] in Serum
10
56
1.68
0.73
1.8
1.6
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
53
408
1.23
0.72
1.2
1.3
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
6
101
0.56
0.72
1.0
1.3
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
6
104
0.54
0.72
1.3
1.4
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
10
150
0.63
0.72
1.5
1.2
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
18
238
0.71
0.70
1.1
1.7
—
6.7
—
0
13
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
27
191
1.33
0.70
1.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
27
191
1.33
0.70
1.0
1.0
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
31
224
1.31
0.70
1.3
1.5
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
63
496
1.20
0.70
1.1
1.3
nmol/l
—
—
—
0
0
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
9
136
0.62
0.69
1.0
1.1
%
103.7
93.9
—
9
103
(3051593) INR in Capillary blood by Coagulation assay
25
311
0.76
0.68
4.7
10.3
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
83
907
0.86
0.67
1.2
1.4
e6/l
768.9
1078.6
0.27
55
748
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
5
88
0.54
0.67
1.0
1.1
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
83
906
0.86
0.67
1.2
1.3
e6/l
6.3
24.4
1.56
53
708
(3024139) IgG subclass 3 [Mass/volume] in Serum
52
406
1.21
0.64
1.2
1.4
g/l
0.5
0.4
0.82
32
292
(3027135) IgG subclass 1 [Mass/volume] in Serum
52
406
1.21
0.64
1.2
1.4
g/l
6.8
7.0
0.21
31
287
(3022145) Colonoscopy Study observation
495
4412
1.06
0.63
1.3
1.3
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
29
212
1.29
0.62
1.1
1.1
—
—
—
0
0
(3016750) Collection duration of Urine
28
338
0.78
0.62
1.8
2.1
min
494.8
496.5
0.03
20
252
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
6
97
0.58
0.62
1.0
1.4
ng/l
122.5
125.4
—
6
97
(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis
8
46
1.64
0.62
2.8
4.8
ug/min
95.1
44.5
—
8
35
(3004716) Salmonella sp identified in Stool by Organism specific culture
148
1546
0.90
0.62
1.2
1.2
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
2128
20497
0.97
0.61
4.6
4.2
ng/l
40.9
78.0
2.93
1752
15672
(3048929) Epstein Barr virus Ab [Presence] in Serum
82
671
1.15
0.60
1.1
1.2
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
379
3798
0.94
0.60
2.1
1.5
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
122
1286
0.89
0.60
1.3
1.4
ug/g
268.7
281.4
0.26
67
774
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
9
132
0.64
0.60
1.0
1.3
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
0
20
0.00
0.60
0.0
3.0
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
19
131
1.37
0.60
2.1
1.8
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
17
115
1.39
0.59
1.1
1.1
—
—
—
0
0
(3026250) Tacrolimus [Mass/volume] in Blood
17
115
1.39
0.59
33.2
31.5
ug/l
7.6
7.3
0.22
12
104
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
229
1994
1.09
0.58
2.1
1.4
g/l
3.4
3.0
7.14
189
1515
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
60
481
1.18
0.58
1.1
1.2
u/ml
295.2
294.3
0.01
40
293
(3026008) Bacteria identified in Urine by Culture
1568
14394
1.03
0.57
3.0
3.2
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
17
116
1.38
0.57
1.1
1.3
—
—
—
0
0
(3034426) Prothrombin time (PT)
17
116
1.38
0.57
1.1
1.3
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
112
1181
0.89
0.57
4.4
3.6
mg/l
38.3
28.8
1.42
83
804
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
28
207
1.28
0.57
1.1
1.1
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
5
81
0.58
0.56
1.6
2.5
u/field
0.0
0.4
—
5
81
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
64
519
1.16
0.55
1.1
1.2
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
16
109
1.38
0.54
1.3
1.2
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
555
5478
0.95
0.54
1.3
1.3
titre
582.7
524.3
0.32
139
1239
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
8
119
0.63
0.54
1.0
1.1
—
—
—
0
0
(4062490)
51
406
1.19
0.54
1.2
1.4
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
10
62
1.52
0.52
1.2
2.0
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
91
760
1.13
0.52
3.0
2.4
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
9
59
1.44
0.52
1.9
1.6
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
12
78
1.45
0.52
1.2
1.2
—
—
—
0
0
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
9
126
0.67
0.52
3.7
2.6
nmol/l
151.6
140.4
—
9
112
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
9
60
1.41
0.51
1.1
1.2
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
26
307
0.80
0.51
1.0
1.1
u/ml
0.5
0.9
—
10
120
(3035285) Chloride [Moles/volume] in Venous blood
92
772
1.12
0.50
3.0
2.4
mmol/l
104.4
106.0
2.21
92
764
(3041354) Potassium [Moles/volume] in Venous blood
92
772
1.12
0.50
3.0
2.4
mmol/l
4.2
4.1
0.39
92
765
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
200
1746
1.08
0.50
2.5
1.5
mg/l
41.7
40.6
0.05
155
1396
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
15
103
1.37
0.50
1.1
1.1
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
46
509
0.85
0.48
2.0
2.3
ml
653.8
634.4
0.09
30
336
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
7
43
1.53
0.48
1.0
1.1
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
200
1751
1.08
0.47
2.5
1.6
mg/l
49.8
50.7
0.07
152
1407
(3021788) Differential panel - Synovial fluid
95
997
0.90
0.47
1.3
1.4
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
81
858
0.89
0.47
1.4
1.3
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
100
1046
0.90
0.47
1.2
1.2
mg/l
801.2
557.3
0.44
95
974
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
7
45
1.47
0.47
1.7
1.2
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
16
113
1.34
0.46
1.1
1.1
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
15
105
1.35
0.45
1.0
1.0
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
151
1542
0.92
0.44
4.5
4.0
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
27
311
0.82
0.44
1.0
1.1
u/ml
5.4
2.4
—
9
137
(4133840)
12
81
1.40
0.44
1.5
1.2
—
—
—
0
0
(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine
7
48
1.37
0.44
1.4
2.5
—
34.5
—
0
12
(3006922) Hepatitis E virus Ab [Presence] in Serum
27
207
1.23
0.43
1.0
1.1
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
242
2144
1.07
0.43
2.1
1.4
g/l
8.1
7.4
4.65
190
1533
(44813793)
21
247
0.80
0.42
1.1
1.1
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
241
2138
1.06
0.41
2.1
1.4
g/l
4.1
3.9
0.64
185
1480
(3027456) Digoxin [Moles/volume] in Serum or Plasma
152
1326
1.08
0.41
3.0
3.0
nmol/l
0.8
0.8
0.09
118
1025
(3027401) Testosterone Free/Testosterone.total in Serum or Plasma
0
14
0.00
0.41
0.0
1.1
—
1.3
—
0
14
(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum
0
14
0.00
0.41
0.0
1.0
—
0.0
—
0
7
(3035082) Kappa light chains [Mass/volume] in Urine
0
14
0.00
0.41
0.0
1.0
—
0.0
—
0
5
(3041672) Baker's yeast Ab [Presence] in Serum
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3016426) Methylmalonate [Moles/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
1.1
—
244.8
—
0
16
(3038515) Glucose [Moles/volume] in Venous blood
127
1300
0.92
0.41
4.5
3.5
mmol/l
7.3
7.8
2.23
127
1268
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
32
1.47
0.40
1.2
1.0
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
27
307
0.83
0.40
1.2
1.2
mmol/l
7.4
11.7
—
6
91
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
241
2142
1.06
0.40
2.1
1.4
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
70
589
1.12
0.39
1.4
1.3
mu/l
149.5
70.2
0.86
57
519
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
5
33
1.43
0.39
1.0
1.3
—
—
—
0
0
(3004593) Baker's yeast IgA Ab [Units/volume] in Serum
0
18
0.00
0.39
0.0
1.0
—
37.2
—
0
5
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
18
0.00
0.39
0.0
1.0
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
18
0.00
0.39
0.0
1.4
—
—
—
0
0
(3008092) Baker's yeast IgG Ab [Units/volume] in Serum
0
18
0.00
0.39
0.0
1.0
—
18.0
—
0
5
(3022493) Free Hemoglobin [Mass/volume] in Plasma
18
213
0.80
0.38
1.2
4.3
mg/l
77.5
78.9
—
10
137
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
26
202
1.21
0.38
2.1
2.2
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
9
62
1.37
0.38
1.1
1.2
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
149
1509
0.93
0.38
1.2
1.2
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
133
1161
1.08
0.37
1.5
1.5
g/l
0.2
0.2
0.14
124
1091
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
191
1692
1.07
0.36
2.5
1.5
ratio
5.0
2.3
—
10
140
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
9
67
1.27
0.36
1.3
1.1
—
—
—
0
0
(3017704) Immunofixation for Urine
27
301
0.84
0.34
1.7
1.2
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
325
2931
1.05
0.34
4.1
3.1
e9/l
5.1
4.2
4.60
248
2045
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
121
1058
1.08
0.34
1.5
1.5
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
41
441
0.88
0.34
1.0
1.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
39
320
1.15
0.33
1.6
1.6
—
—
—
0
0
(3039744) RNA polymerase III Ab [Units/volume] in Serum
6
43
1.32
0.33
1.2
1.0
—
2.5
—
0
7
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
6
85
0.66
0.32
1.0
1.0
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
63
535
1.11
0.32
1.0
1.0
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
25
198
1.19
0.32
1.0
1.1
—
—
—
0
0
(3012565) Volume of 24 hour Urine
27
216
1.18
0.31
2.0
2.1
ml
1797.9
1920.1
0.21
21
182
(3027008) Opiates [Presence] in Urine
39
322
1.14
0.31
1.6
1.6
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
572
5231
1.03
0.31
2.9
3.2
ng/l
191.4
258.3
3.85
532
4811
(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid
7
50
1.32
0.30
1.0
1.2
—
35.5
—
0
14
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
7
50
1.32
0.30
1.0
1.1
—
—
—
0
0
(3001729) Color of Synovial fluid
7
51
1.29
0.30
1.7
1.6
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
35
288
1.15
0.30
1.8
2.2
mmol/l
8.3
9.3
0.76
26
216
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
29
316
0.86
0.29
1.1
1.1
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
10
71
1.33
0.29
2.5
2.3
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
15
114
1.24
0.28
1.1
1.1
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
14
163
0.81
0.28
1.2
1.3
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
270
2650
0.96
0.27
4.6
4.0
%
46.6
47.0
0.10
270
2613
(21494434) Karyotype in Bone marrow
44
371
1.12
0.27
1.1
1.1
—
—
—
0
0
(4306422)
56
479
1.10
0.27
1.2
1.2
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
37
309
1.13
0.26
2.6
2.2
ug/min
82.0
225.8
—
6
79
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
15
115
1.23
0.26
1.1
1.1
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
43
363
1.12
0.26
2.8
2.9
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
8
63
1.20
0.26
1.1
1.2
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
63
544
1.09
0.26
1.3
1.3
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
23
186
1.17
0.25
1.1
1.1
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
27
291
0.87
0.25
2.1
2.5
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
101
1015
0.94
0.25
1.2
1.1
titre
197.0
114.6
—
10
78
(3016879) Cocaine [Presence] in Urine
36
302
1.12
0.24
1.7
1.7
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
133
1189
1.06
0.23
1.6
1.5
g/l
1.1
1.2
0.94
124
1114
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
387
3754
0.97
0.23
4.8
2.5
ml/min/173m2
62.1
60.4
0.46
168
1501
(3047189) Immunofixation for 24 hour Urine
24
197
1.15
0.22
1.6
1.1
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
64
558
1.08
0.22
1.4
1.3
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
18
144
1.18
0.22
1.1
1.1
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
5
38
1.24
0.22
1.0
1.1
—
—
—
0
0
(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma
5
38
1.24
0.22
1.2
1.1
ug/l
94.4
77.5
—
5
30
(3028300) Cannabinoids [Presence] in Urine
38
323
1.11
0.22
1.6
1.6
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
5
39
1.21
0.22
1.0
1.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
30
317
0.89
0.21
1.3
1.6
—
—
—
0
0
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
4.4
—
—
—
0
0
(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3027540) Rickettsia typhi Ab [Titer] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3006969) Lambda light chains [Mass/volume] in Urine
0
11
0.00
0.21
0.0
1.0
—
0.0
—
0
5
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
91
911
0.94
0.21
1.2
1.2
mmol/l
3.8
4.0
1.30
85
841
(3012989) Citrate [Moles/time] in 24 hour Urine
0
12
0.00
0.21
0.0
1.4
—
2.2
—
0
12
(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay
0
12
0.00
0.21
0.0
2.1
—
3.1
—
0
12
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
0
12
0.00
0.21
0.0
4.8
—
405.5
—
0
12
(3011841) English Walnut IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
0.0
—
0
7
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
21
172
1.15
0.20
1.1
1.1
u/l
1.0
1.1
0.50
13
74
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
13
0.00
0.20
0.0
1.1
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
13
0.00
0.20
0.0
1.0
—
—
—
0
0
(40762814) Titanium [Mass/volume] in Blood
11
126
0.82
0.20
2.2
2.3
ug/l
7.4
3.5
—
5
40
(3050129) First trimester maternal screen panel - Serum or Plasma
6
46
1.23
0.20
1.7
1.2
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
9
105
0.81
0.20
1.2
2.3
ug/l
1.2
1.0
—
9
96
(44806420)
18
196
0.87
0.20
2.3
2.4
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
47
1.20
0.19
1.2
1.0
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
13
102
1.20
0.19
1.1
1.2
—
—
—
0
0
(44806071)
6
48
1.18
0.19
1.3
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
39
335
1.10
0.19
1.0
1.1
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
10
115
0.82
0.19
1.1
1.2
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
54
472
1.08
0.19
1.2
1.1
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
16
175
0.86
0.18
1.1
1.2
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
14
112
1.18
0.17
2.6
2.4
e6/l
8638.5
31310.6
—
8
62
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
7
57
1.16
0.17
1.4
1.4
—
—
—
0
0
(3048879) Bone marrow aspiration report
15
121
1.17
0.17
1.1
1.1
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
69
691
0.94
0.17
3.4
2.2
mg/l
29.5
27.9
0.07
22
173
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
93
922
0.95
0.17
1.2
1.2
—
11.4
—
0
10
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
7
59
1.12
0.17
1.1
1.1
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
75
748
0.94
0.17
1.3
1.2
u/ml
62.6
42.8
—
9
88
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
5
64
0.74
0.17
1.2
1.1
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
33
340
0.91
0.16
1.3
1.2
promille
1.3
1.2
0.21
27
254
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
6
74
0.76
0.15
1.0
1.1
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
410
3787
1.02
0.15
2.8
3.8
ng/l
80.4
99.7
6.29
363
3159
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
20
168
1.12
0.14
2.3
2.5
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
7
85
0.78
0.14
1.0
1.2
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
29
250
1.09
0.14
1.8
1.6
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
24
205
1.10
0.14
1.8
2.4
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
25
258
0.91
0.13
1.4
1.8
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
36
315
1.08
0.13
1.7
1.5
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
20
209
0.90
0.13
1.1
1.3
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
27
277
0.92
0.13
1.0
1.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
93
841
1.04
0.13
1.2
1.4
—
—
—
0
0
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
9
103
0.82
0.13
1.3
1.5
%
184.3
205.5
—
9
95
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
55
491
1.06
0.12
1.1
1.1
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
15
159
0.89
0.12
2.9
2.0
ug/l
38.4
49.2
0.82
15
154
(3031040) Bacteria [#/volume] in Urine by Automated count
3238
30637
0.99
0.11
4.5
4.5
e6/l
194.3
1476.6
4.04
63
562
(40768797) Stomach Pathology biopsy report
657
6267
0.99
0.11
1.4
1.2
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
89
807
1.04
0.11
1.2
1.3
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
26
226
1.08
0.11
1.4
1.7
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
15
126
1.12
0.11
1.1
1.1
—
—
—
0
0
(40768443) Skin Pathology biopsy report
205
1891
1.02
0.10
1.2
1.2
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
14
147
0.90
0.10
1.1
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
14
147
0.90
0.10
1.1
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
14
147
0.90
0.10
1.1
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
14
147
0.90
0.10
1.1
1.1
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
29
255
1.07
0.10
1.1
1.4
u/l
13.3
6.5
0.61
24
213
(3032773) Endomysium IgG Ab [Titer] in Serum
30
302
0.94
0.10
1.0
1.1
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
95
867
1.03
0.09
1.2
1.2
u/ml
9.8
5.3
—
9
67
(3034092) Cytoplasmic Ig cells/100 cells in Blood
5
45
1.05
0.09
14.8
11.9
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
42
376
1.05
0.09
1.2
1.2
u/ml
1.4
60.6
—
5
13
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
31
275
1.06
0.08
1.1
1.1
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
12
126
0.90
0.08
2.6
2.9
mu/l
7.0
23.9
5.47
12
116
(3019779) Phenytoin [Moles/volume] in Serum or Plasma
5
61
0.77
0.08
1.8
2.1
umol/l
36.4
44.2
—
5
50
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
32
285
1.06
0.08
1.1
1.2
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
6
67
0.84
0.07
1.2
1.5
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
6
71
0.80
0.07
1.5
1.9
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
28
279
0.95
0.07
1.0
1.0
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
11
115
0.90
0.07
1.4
1.6
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
11
115
0.90
0.07
2.2
1.5
—
—
—
0
0
(3001686) Cold agglutinin [Titer] in Serum or Plasma
9
82
1.03
0.07
1.2
1.2
—
53.0
—
0
10
(3008116) Ketones [Moles/volume] in Urine by Test strip
11
93
1.11
0.06
1.5
1.3
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
9
95
0.89
0.06
1.0
1.1
—
—
—
0
0
(4268621)
37
334
1.04
0.06
2.1
2.3
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
18
158
1.07
0.06
1.0
1.0
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
40
392
0.96
0.06
1.3
1.6
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
19
191
0.94
0.06
1.9
1.4
u/l
24.6
1586.4
—
8
69
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
28
277
0.95
0.05
1.4
1.8
u/field
2.4
1.8
0.19
20
193
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
447
4247
0.99
0.05
1.3
1.3
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
88
848
0.98
0.05
1.2
1.3
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
33
324
0.96
0.05
1.1
1.1
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
111
1027
1.02
0.05
1.3
1.2
u/ml
7.5
5.4
0.34
22
167
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
47
457
0.97
0.05
1.1
1.2
miu/ml
76.1
218.2
—
7
156
(3015171) Extractable nuclear Ab [Units/volume] in Serum
163
1557
0.99
0.05
1.2
1.2
u/ml
0.3
0.7
1.91
14
165
(3044007) Cell count panel - Peritoneal fluid
12
104
1.09
0.04
3.3
2.3
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
15
132
1.07
0.04
2.5
2.7
e6/l
687.7
981.0
—
9
97
(3042733) HLA Ab [Presence] in Serum
11
95
1.09
0.04
3.4
5.1
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
60
552
1.02
0.04
1.1
1.3
pmol/l
304.4
262.2
0.57
46
409
(21494890) Protein electrophoresis panel - 24 hour Urine
54
496
1.03
0.04
1.8
1.3
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
15
133
1.06
0.03
9.2
10.9
nmol/l
970.2
797.0
0.43
15
124
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
40
367
1.03
0.03
1.2
1.2
u/ml
24.5
36.8
—
6
29
(3004119) Hemoglobin [Mass/volume] in Venous blood
359
3401
0.99
0.02
3.4
3.2
g/l
122.3
130.2
8.90
354
3310
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
11
111
0.93
0.02
1.1
1.1
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
109
1016
1.01
0.02
1.3
1.2
u/ml
2.5
6.2
0.68
13
104
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
15
134
1.06
0.02
1.2
1.1
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
14
139
0.95
0.02
1.0
1.0
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
16
144
1.05
0.01
1.2
1.6
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
19
186
0.96
0.01
1.0
1.1
iu/ml
6.4
14.7
—
8
45
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
19
186
0.96
0.01
1.1
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
129
1222
0.99
0.00
1.1
1.2
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
17
158
1.01
0.00
1.2
1.4
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
19
181
0.99
0.00
2.9
2.6
umol/l
30.4
28.8
0.27
14
135
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
44
414
1.00
0.00
1.3
1.4
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
44
414
1.00
0.00
1.3
1.3
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
15
137
1.03
0.00
1.1
1.2
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
39
364
1.01
0.00
1.2
1.1
u/ml
62.2
84.3
—
5
16
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
20
184
1.02
0.00
1.1
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
129
1216
1.00
0.00
1.1
1.2
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
168
1587
1.00
0.00
2.4
2.4
g/l
0.4
0.3
0.14
80
560
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
128
1206
1.00
0.00
1.1
1.2
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
12
112
1.01
0.00
1.1
1.1
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
59
559
0.99
0.00
1.2
1.4
—
—
—
0
0
(3024263) Appearance of Synovial fluid
31
287
1.02
0.00
1.5
1.6
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
90
846
1.00
0.00
1.1
1.1
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
230
2170
1.00
0.00
1.3
1.3
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
10
94
1.00
0.00
1.0
1.1
%
100.0
86.5
—
5
43
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
10
94
1.00
0.00
1.0
1.1
%
97.2
85.7
—
5
46
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
116
1093
1.00
0.00
1.3
1.2
u/ml
36.5
44.7
0.16
11
66
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
63
590
1.01
0.00
1.2
1.1
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
7
72
0.92
0.00
1.0
1.0
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763641) Cell count and Differential panel - Peritoneal dialysis fluid
0
5
0.00
0.00
0.0
2.6
—
—
—
0
0
(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma
6
56
1.01
0.00
1.2
1.3
%
79.3
70.7
—
6
51
(40760409) HLA-A [Type] by High resolution
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
6
60
0.94
0.00
1.2
1.1
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3034614) HLA Ag [Interpretation]
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count
0
8
0.00
0.00
0.0
6.1
—
—
—
0
0
(3008640) Bordetella pertussis IgG Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
7
68
0.97
0.00
5.3
12.5
mmol/l
5.7
5.1
—
7
68
(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count
0
7
0.00
0.00
0.0
3.9
—
18.1
—
0
7
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma
6
56
1.01
0.00
1.2
1.3
mu/l
292.8
765.3
—
6
51
(40763590) HLA-DQ beta [Type]
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
6
59
0.96
0.00
1.2
1.1
—
—
—
0
0
(3013862) HLA-DP [Type]
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014171) Thiocyanate [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
121.4
—
0
5
(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.3
—
1.4
—
0
9
(40769427) Triglyceride [Moles/volume] in Peritoneal fluid
0
5
0.00
0.00
0.0
1.0
—
1206.0
—
0
5
(3024471) HLA-A [Type]
9
86
0.99
0.00
1.1
1.0
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009677) Dengue virus Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002331) Protein [Mass/volume] in Peritoneal fluid
9
92
0.92
0.00
1.2
1.5
g/l
24.3
86.5
—
9
75
(3009871) Measles virus Ab [Titer] in Serum
9
88
0.96
0.00
1.6
1.6
—
—
—
0
0
(3046682) IgA [Presence] in Skin by Immunofluorescence
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027696) Helicobacter pylori Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.1
—
1075.0
—
0
8
(3003531) Amoxicillin IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014591) Smooth Alder IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
9
85
1.00
0.00
1.1
1.0
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028714) Urate [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(40762887) Creatinine [Moles/volume] in Blood
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_LUNG_NONSMALL_EXALLC – Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)
GWS hits: 7
This endpoint is excluded (different definition than used in FinnGen).